fevkhtm form evk table contents securities and exchange commission washington dc form annual report pursuant to section or of the securities exchange act of for fiscal year ended march or transition report pursuant to section or of the securities exchange act of commission file number mckesson corporation delaware corporation irs employer identification number mckesson plaza one post street san francisco ca telephone securities registered pursuant sectionb act title each class common stock par value name each exchange which registered new york stock exchange securities registered pursuant sectiong act none indicate check mark whether registrant well known seasoned issuer defined inrule securities act yes no indicate check mark whether registrant required file reports pursuant tosection act yes no indicate check mark whether registrant filed reports required filedby section securities exchange act preceding months orfor shorter period registrant required file reports beensubject filing requirements past days yes no indicate check mark disclosure delinquent filers pursuant item regulations contained herein contained best registrants knowledge indefinitive proxy information statements incorporated reference partiii form kor amendment form indicate check mark whether registrant shell company defined ruleb ofthe exchange act yes no indicate check mark whether registrant large accelerated filer acceleratedfiler non accelerated filer see definition accelerated filer large acceleratedfiler ruleb exchange act check one large accelerated filer accelerated filer non accelerated filer the aggregate market value voting stock held non affiliates registrantcomputed reference closing price last business day registrants mostrecently completed second fiscal quarter september approximately billion number shares common stock outstanding april documents incorporated by reference portions registrants proxy statement annual meeting stockholders areincorporated reference partiii annual report form table of contents item page part business risk factors unresolved staff comments properties legal proceedings submission matters vote security holders executive officers registrant part ii market registrants common equity related stockholder matters issuer purchases equity securities stock price performance graph selected financial data managements discussion analysis results operations financial condition quantitative qualitative disclosures about market risk financial statements supplementary data changes disagreements accountants accounting financial disclosure controls procedures other information part iii directors executive officers corporate governance executive compensation security ownership certain beneficial owners management related stockholder matters certainrelationships related transactions director independence principalaccounting fees services part iv exhibits financial statement schedule signatures exhibit exhibit exhibit exhibit exhibit exhibit exhibit table contents mckesson corporation part item business general mckesson corporation mckesson company registrant similarpronouns fortune corporation providing supply information care management productsand services designed reduce costs improve quality across healthcare industry the companys fiscal year begins april ends march unless otherwise noted allreferences document particular year shall mean companys fiscal year our annual report form quarterly reports form current reports form kand amendments reports filed furnished pursuant section thesecurities exchange act exchange act amended available free charge onour web site wwwmckessoncom investors sec filings caption soon asreasonably practicable electronically file material furnish thesecurities exchange commission sec commission the content web sitereferred annual report form incorporated reference reportunless expressly noted otherwise business segments we conduct business three segments through pharmaceutical solutions segmentwe leading distributor ethical proprietary drugs health beauty care productsthroughout north america this segment also provides medical management specialtypharmaceutical solutions biotech pharmaceutical manufacturers patient servicesfor payors software consulting outsourcing services pharmacies itsinvestment parata systems llc parata sells automated pharmaceutical dispensing systems forretail pharmacies our medical surgical solutions segment distributes medical surgical suppliesfirst aid products equipment provides logistics services within unitedstates canada our provider technologies segment delivers enterprise wide patient careclinical financial supply chain strategic management software solutions pharmacy automationfor hospitals well connectivity outsourcing services healthcare organizationsthroughout north america united kingdom european countries its customers includehospitals physicians homecare providers retail pharmacies payors the companys strategy isto create strong value based relationships customers enabling us sell additional productsand services customers time net revenues segments last three years follows dollars billions pharmaceutical solutions medical surgical solutions provider technologies total pharmaceutical solutions mckesson pharmaceutical solutions consists following businesses mckesson uspharmaceutical mckesson canada mckesson health solutions mckesson pharmacy systems mckessonmedication management mckesson specialty distribution we also approximate interestin nadro sa de cv nadro approximate interest parata us pharmaceutical distribution this business supplies pharmaceuticals healthcarerelated products customers three primary customer segments retail national accountsincluding national regional chains fooddrug combinations mail order pharmacies massmerchandisers independent retail pharmacies institutional healthcare providersincluding hospitals health systems integrated delivery networks clinics acute carefacilities long term care providers table contents mckesson corporation our us pharmaceutical business operates serves thousands customer locations anetwork distribution centers well master redistribution center strategicredistribution center repackaging facility serving states puerto rico we investin technology systems distribution centers enhance safety reliabilityand best product availability customers for example distributioncenters use acumax plus smithsonian award winning technology integrates tracksall internal functions receiving put away order fulfillment acumax plus uses barcode technology wrist mounted computer hardware radio frequency signals provide ourcustomers real time product availability industry leading order quality fulfillment atup accuracy in addition offer mobile manager sm integrates portablehandheld technology acumax plus give customers complete ordering inventory controlwe also offer supply management online sm internet based tool provides itemlook real time inventory availability well ordering purchasing third partyreconciliation account management functionality together features help ensure ourcustomers right products right time facilities patients to maximize distribution efficiency effectiveness follow six sigma methodology analytical approach emphasizes setting high quality objectives collecting data andanalyzing results fine degree order improve processes reduce costs errorsfurthermore continue implement information systems help achieve greater consistency andaccuracy internally customers our us pharmaceutical distribution business major value added offerings customer groupinclude following retail national accounts business solutions help national accounts increase revenuesand profitability central fill prescription refill service enables pharmaciesto refill prescriptions remotely faster accurately alower cost reducing inventory levels improving customerservice re distribution centers two large facilities offer accessto inventory single source warehouse purchasing includingpharmaceuticals biologicals these distribution centers alsoprovide foundation two tiered distribution network thatsupports best class direct store delivery rxpak sm bulk repackaging service leverages ourpurchasing power supplier relationships providepharmaceuticals reduced prices help increase inventory turnsand reduce working capital investment inventory management an integrated solution comprisingforecasting software automated replenishment technologies thatreduces inventory carrying costs independent retail pharmacies solutions managed care contracting branding andadvertising merchandising purchasing help independent pharmacists focus patient carewhile improving profitability health mart franchise program provides independentpharmacies managed care drives pharmacy benefit managerrecognition branding drives consumer recognition storeexecution programs drive manufacturer recognition andcommunity advocacy programs drive industry recognition accesshealth comprehensive managed care reconciliationassistance services help independent pharmacies save timeaccess competitive reimbursement rates improve cash flow mckesson onestop generics generic pharmaceutical purchasingprogram helps pharmacies maximize cost savings abroad selection rebate eligible generic drugs lower frontpricing one stop shopping prefer rx discount program offers aggressive prices morethan branded drugs helping retail independent pharmaciesincrease margins eliminate rebate paperwork sunmark complete line products provideretail independent pharmacies value priced alternatives tonational brands frontedge strategic planning merchandising pricemaintenance program helps independent pharmacies maximizestore profitability mckesson home health care comprehensive line home health care products including durable medical equipmentdme self care supplies disposables national brandsand high margin sunmark line table contents mckesson corporation institutional healthcare providers electronicorderingpurchasing supply chain management systems help improve efficiencies save laborand improve asset utilization fulfill rx ordering inventory management system thatintegrates mckesson pharmaceutical distribution services ourautomation solutions thus empowering hospitals optimize theoften complicated disjointed processes related unit basedcabinet replenishment inventory management asset management award winning inventory optimization andpurchasing management program helps institutional providerslower costs ensuring product availability sky packaging blister format packaging containing mostwidely prescribed dosages strengths generic oralsolid medications enables acute care long term care andinstitutional pharmacies provide cost effective uniformpackaging mckesson manager software solution manages tracksand reports medication replenishment associated thefederal drug pricing program helping institutional providersmaximize return accesshealth expert service third party contracting andpayment consolidation helps institutional providers save timeand accelerate reimbursement high performance pharmacy framework identifies andcategorizes hospital pharmacy best practices allowing healthsystem executives pharmacy leaders improve clinicaloutcomes financial results international pharmaceutical distribution mckesson canada corporation wholly ownedsubsidiary largest pharmaceutical distributor canada we also approximate interest nadro leading pharmaceutical distributor mexico investment parata we approximate interest parata sells automatedpharmacy supply management systems services retail andinstitutional outpatient pharmacies payor group the following suite services software products marketed payorsemployers government organizations help manage cost quality care disease management programs improve health status health outcomes patients chronic conditions nurse triage services provide health information recommend appropriate levels care clinical analytical software support utilization case disease management workflow business intelligence tools measuring reporting improving clinical financial performance interqual criteria clinical decision support claims performance solutions facilitate accurate efficient medical claim payment mckesson specialty distribution this business product specific solutions directedtowards manufacturers payors physicians enable delivery administration high costoften injectable bio pharmaceutical drugs used treat patients chronic disease thebusiness facilitates patient provider access specialty pharmaceuticals across multipledelivery channels direct physician wholesale patient direct specialty pharmacy dispensing andaccess retail pharmacy provides clinical support treatment compliance programs helppatients stay complex therapies offers reimbursement data collection analysis services medicalsurgical solutions our medical surgical solutions segment provides medical surgical supply distributionequipment logistics services healthcare providers include physicians officessurgery centers extended care facilities homecare occupational health sites networkof distribution centers within us this segment leading provider supplies thefull range alternate site healthcare facilities including physicians offices clinics andsurgery centers primary care long term care occupational health facilities homecare sitesextended care through variety technology products services geared towards supplychain medical surgical solutions focused helping customers operate efficientlywhile providing industrys extensive product offering including private labelline this segment also includes zee medical north americas leading provider first aidsafety training solutions providing services industrial commercial customers thisbusiness offers extensive line products services aimed maximizing productivity andminimizing liability cost associated workplace illnesses injuries table contents mckesson corporation provider technologies our provider technologies segment provides comprehensive portfolio software automationsupport services help healthcare organizations improve quality patient safety reducethe cost variability care better manage resources revenue stream thissegment markets products services integrated delivery networks hospitals physician practices home health providers retail pharmacies payors the segment also sells itssolutions internationally subsidiaries andor distribution agreements canada unitedkingdom ireland france netherlands australia new zealand israel the product portfolio provider technologies segment designed address widearray healthcare clinical business performance needs ranging medication safety andinformation access revenue cycle management resource utilization physician adoption ofelectronic health records ehr analytics software enables organizations measure progress asthey automate care processes optimal clinical outcomes business operating results andregulatory compliance to ensure organizations achieve maximum value theirinformation technology investment provider technologies segment also offers wide range ofservices support implementation use solutions well assist business andclinical redesign process engineering staffing information technology andback office key solution areas follows clinical management horizon clinicals built architecture facilitateintegrationand enable modular system deployment it includes clinical data repository clinical decisionsupportphysician order entry point care documentation bar coded medicationadministration enterprise laboratory radiology pharmacy surgical management emergencydepartment solution ambulatory ehr system horizon clinicals also includes solutions tofacilitate physician access patient information web based physician portal andwireless devices draw information hospitals information systems in additionthe horizon clinicals suite includes comprehensive solution homecare including telehealthand hospice enterprise imaging in addition document imaging facilitate maintenance access tocomplete medical records segment provides suite enterprise medical imaging andinformation management systems including picture archiving communications system acomprehensive cardiovascular information system the segments enterprise wide approach medicalimaging enables organizations take advantage specialty specific workstations buildingan integrated image repository manages images information captured throughoutthe care continuum revenue cycle management the segments revenue cycle solutions designed reduce daysin accounts receivable prevent insurance claim denials reduce costs improve productivityexamples solutions include online patient billing contract management electronic claimsprocessing coding compliance checking the segments hospital information systems play keyrole managing revenue cycle automating operation individual departments theirrespective functions within inpatient environment resource management resource management solutions consist integrated suite ofapplications enhance organizations ability forecast optimize enterprise wide use ofresources labor supplies equipment facilities associated delivery care thesesolutions help automate link resource requirements care protocols designed increaseprofitability enhance decision making improve business processes automation automation solutions include technologies help hospitals engineer andimprove medication use supply management processes examples include centralizedpharmacy automation unit dose medications unit based cabinet technologies securemedication storage rapid retrieval point use supply automation systems inventorymanagement revenue capture automated medication administration system ensuringaccuracy point care based foundation bar code scanning technology theseintegrated solutions designed reduce errors bring new levels safety patients physician practice solutions the segment provides complete solution physicianpractices sizes includes software revenue cycle outsourcing connectivity servicessoftware solutions include practice management ehr software physicians every sizespecialty geographic location the segments physician practice offering also includesoutsourced billing collection services well services connect physicians theirpatients hospitals retail pharmacies payors revenue cycle outsourcing enables physician table contents mckesson corporation groups avoid infrastructure investment administrative costs housebilling office services include clinical data collection data input medical coding billingcontract management cash collections accounts receivable management extensive reporting ofmetrics related physician practice connectivity following acquisition per se technologies inc january weannounced vendor neutral connectivity business known relayhealth the relayhealth intelligent network includes interactive connectivity solutions streamline clinicalfinancial administrative communication patients providers payors pharmacies andfinancial institutions relayhealth helps accelerate delivery high quality care andimprove financial performance solutions online consultation physiciansby patients electronic prescribing physicians point service resolution pharmacy claimsby payors pre visit financial clearance patients providers post visit settlement ofprovider bills payors patients in addition product offerings described provider technologies segment offersa comprehensive range services help organizations derive greater value enhance satisfactionand return investment throughout life solutions implemented the range servicesincludes technology services the segment worked numerous healthcare organizations supportthe smooth operation information systems providing technical infrastructuredesigned maximize application accessibility availability security performance professional services professional services help customers achieve business results fromtheir software automation investment the segment offers wide array quality serviceoptions including consulting business andor clinical process improvement design aswell implementation project management technical education services relating allproducts provider technologies segment outsourcing services the segment helps organizations focus resources healthcarewhile segment manages information technology revenue cycle operations throughoutsourcing outsourcing service options include managing hospital data processing operations aswell strategic information systems planning management revenue cycle processes payrollprocessing business office administration major system conversions acquisitions investments discontinued operations we undertaken strategic initiatives recent years designed focus corehealthcare businesses enhance competitive position we expectto continue undertake strategic initiatives future these initiatives detailed infinancial notes consolidated financial statements acquisitions investmentsand discontinued operations appearing annual report form competition in every area healthcare distribution operations pharmaceutical solutions andmedical surgical solutions segments face strong competition price service fromnational regional local full line short line specialty wholesalers servicemerchandisers self warehousing chains manufacturers engaged direct distribution largepayor organizations in addition segments face competition various serviceproviders pharmaceutical healthcare manufacturers well potentialcustomers segments may time time decide develop internalneeds supply management capabilities provided segments price quality service insome cases convenience customer generally principal competitive elements thesesegments our provider technologies segment experiences substantial competition many firmsincluding computer services firms consulting firms shared service vendors certainhospitals hospital groups hardware vendors internet based companies technologyapplicable healthcare industry competition varies size small large companiesin geographical coverage scope breadth products services offered table contents mckesson corporation intellectual property the principal trademarks service marks pharmaceutical solutions andmedical surgical solutions segments include accesshealth acumax ask nurse careenhance closed loop distribution sm comets consumerscript sm crms com pharmacysolutions econolink empowering healthcare enterpriserx episode profiler expect more frommoore sm frontedge fulfill rx health mart high performancepharmacy sm interqual loyaltyscript sm max impact sm mckesson mckesson advantage mckesson empowering healthcare mckesson max rewards mckesson onestopgenerics mckessonpriority express mckesson supply manager sm medinet medi pak mobilemanager sm moore medical moorebrand sm noa patterns profilerpharma pharmacyrx pharmaserv pharmassure sm prointercept promed propbm rxpak sm rx savings access servicefirst staydry sunmark supply managementonline sm trialscript valu rite xviii medimart zee the substantial majority technical concepts codes embodied provider technologiessegments computer programs program documentation principally protected trade secretsthe principal trademarks service marks segment care fully connectedhealthquest paragon pathways trendstar horizon clinicals horizonwp seriesstar practicepoint robot rx medcarousel pacmed acudose rx carepoint rnconnect rx connect rn horizon admin rx pak plus rx selfpace fulfill rx sm andsupplyscan per se technologies logo per se peryourhealthcom orsos one call one staff ansos premis datastat medisoft epremis lytec scriptwebvisitrelayhealth practice partner physician microsystems we also registered unregistered trademarks service marks similar rightsused business segments all principal trademarks service marks registered inthe united states registrations applied respect marks additionto certain jurisdictions the united states federal registrations trademarks haveterms ten twenty years depending date registration subject unlimitedrenewals we believe taken necessary steps preserve registration durationof trademarks service marks although assurance given able tosuccessfully enforce protect rights thereunder event subject tothird party infringement claims we consider particular patent license franchise orconcession material business we also hold copyrightsin patents related many products other information about business customers in recent years significant portion revenue growth alimited number large customers during sales largest customer caremark rx incand ten largest customers accounted approximately total consolidatedrevenues at march accounts receivable caremark rx inc ten largestcustomers approximately total accounts receivable the majority theserevenues accounts receivable included pharmaceutical solutions segment suppliers we obtain pharmaceutical products manufacturers none whichaccounted approximately purchases the loss supplier couldadversely affect business alternate sources supply unavailable we believe ourrelationships suppliers whole good the ten largest suppliers accounted forapproximately purchases over past years us pharmaceutical distribution business changed iscompensated logistical capital administrative services provides brandedpharmaceutical manufacturers historically significant portion compensation themanufacturers inflation based we purchased held pharmaceutical inventory anticipationof manufacturers increasing prices we benefited manufacturers increased theirprices sold inventory held new higher prices commencing brandedpharmaceutical manufacturers implemented number changes restricting volume ofproduct available purchase pharmaceutical wholesalers these changes limited ability topurchase inventory advance price increases led volatility gross profit in manufacturers also reduced number average magnitude price increases by early revised distribution arrangements manufacturersunder new arrangements significant portion compensation manufacturers isgenerated based percentage purchases result longer dependent uponpharmaceutical price increases we continue certain distribution arrangements withmanufacturers include inflation based compensation component arrangementsremain structured historical inflation based compensation model table contents mckesson corporation for manufacturers reduction frequency magnitude price increases wellas restrictions amount inventory available us could adversely impact gross profitmargin in benefited certain branded manufacturers price increases selecteddrugs in addition transition new arrangements purchases certainmanufacturers better aligned customer demand result net financial inventoryinventory net accounts payable decreased this decrease positive impact ourcash flow operations these new arrangements also somewhat diminished seasonality ofgross profit margin historically reflected pattern manufacturers price increases research development our research development rd expenditures primarily consistof investment software development held sale we expended million millionand million rd activities amounts capitalized rd expenditures primarily incurred provider technologies segment andpayor group our provider technologies segments product development efforts apply computertechnology installation methodologies specific information processing needs hospitalswe believe substantial sustained commitment expenditures important thelong term success business additional information regarding rd activities isincluded financial note consolidated financial statements significant accountingpolicies appearing annual report form environmental legislation we sold chemical distribution operations retainedresponsibility certain environmental obligations agreements environmental protectionagency certain states may require environmental assessments cleanups several closedsites these matters described financial note other commitments contingentliabilities appearing annual report form other expenditures may required connection legalmatters anticipate making substantial capital expenditures either environmentalissues comply environmental laws regulations future the amount ourcapital expenditures environmental compliance material expected tobe material next year employees on march employed approximately persons compared financial information about foreign domestic operations information foreign anddomestic operations included financial notes consolidated financialstatements significant accounting policies segments business appearing annualreport form table contents mckesson corporation itema risk factors information regarding risk factors included financial review captionsfactors affecting forward looking statements additional factors that may affect futureresults beginning page annual report form itemb unresolved staff comments not applicable item properties because nature principal businesses plant warehousing office otherfacilities operated widely dispersed locations the warehouses typically owned orleased long term basis we consider operating properties satisfactory conditionand adequate meet needs next several years without making capital expendituresmaterially higher historical levels information material lease commitments includedin financial note consolidated financial statements lease obligations appearing inthis annual report form item legal proceedings certain legal proceedings involved discussed financial note ourconsolidated financial statements other commitments contingent liabilities appearing inthis annual report form item submission matters vote security holders no matters submitted vote security holders solicitation proxiesor otherwise three months ended march table contents mckesson corporation executive officers registrant the following table sets forth information regarding executive officers companyincluding principal occupations past five years the number years servicewith company includes service predecessor companies there family relationships executive officers directors thecompany the executive officers chosen annually serve first meeting boardof directors following next annual meeting stockholders successors areelected qualified death resignation removal whichever sooner name age position registrant business experience john hammergren chairman board since july president chief executive officer sinceapril co president co chiefexecutive officer july april director since july servicewith company years jeffrey campbell executive vice president chief financialofficer since april chief financialofficer since december senior vicepresident since january senior vicepresident chief financial officer amrcorporation vice president europe service company years paul julian executive vice president group president sinceapril senior vice president since august president supply solutionsbusiness since march service thecompany years paul kirincic executive vice president human resources sinceapril senior vice president humanresources since january vice presidenthuman resources consumer health sector warnerlambert service company years marc owen executive vice president corporate strategyand business development since aprilsenior vice president corporate strategy andbusiness development since octoberconsultant company april september joined company service withthe company years pamela pure executive vice president president mckessonprovider technologies since aprilmckesson information solutions chief operatingofficer group president chief operating officer channelhealth service company years laureen seeger executive vice president general counsel andsecretary since march vice president andgeneral counsel mckesson provider technologies service company years randall spratt executive vice president chief informationofficer since july senior vicepresident chief process officer mckessonprovider technologies senior vicepresident imaging technology businessprocess improvement senior vicepresident technology standards mckessoninformation solutions servicewith company years table contents mckesson corporation part ii item market registrants common equity related stockholder matters issuer purchases equity securities stockprice performance graph market information the principal market companys common stock traded isthe new york stock exchange nyse high low prices common stock quarter areincluded financial note consolidated financial statements quarterly financialinformation unaudited appearing annual report form holders the number record holders companys common stock march wasapproximately dividends dividend information included financial note consolidatedfinancial statements quarterly financial information unaudited appearing annualreport form share repurchase plans the following table provides information companys sharerepurchases fourth quarter share repurchases approximate total number dollar value shares purchased shares may as part publicly yet be purchased total number average price paid announced under in millions except price per share shares purchased per share program programs january january february february march march total on july companys board directors board approved plan torepurchase total million companys common stock the company completedthis plan fourth quarter this table include shares tendered satisfy exercise price connection withcashless exercises employee stock options shares tendered satisfy tax withholdingobligations connection employee equity awards on april board approved additional share repurchase plan billion companys common stock table contents mckesson corporation stock price performance graph the following graph compares cumulative total stockholderreturn companys common stock periods indicated standard poors index value line health care sector index composed companies healthcare industry including company march mckesson corporation sp index value linehealthcare sectorindex assumes invested mckessoncommon stock index march dividends reinvested item selected financial data selected financial data presented five year highlights section annual report form item managements discussion analysis results operations financial condition managements discussion analysis companys results operations financialcondition presented financial review section annual report form table contents mckesson corporation itema quantitative qualitative disclosures market risk information required item included financial review section annual report onform item financial statements supplementary data financial statements supplementary data included separate sections annual report onform see item item changes disagreements accountants accounting financial disclosure not applicable itema controls procedures disclosure controls procedures our chief executive officer chief financial officer participation othermembers companys management evaluated effectiveness companys disclosurecontrols procedures defined exchange act rulesa theend period covered report concluded disclosure controls andprocedures effective based evaluation controls procedures required byparagraph bof exchange act rulesa internal control financial reporting managements report companys internal control financial reporting termis defined rulesa exchange act related report ourindependent registered public accounting firm included page page annualreport form headings managements annual report internal control overfinancial reporting report independent registered public accounting firm areincorporated herein reference changes internal controls there changes internal control financial reporting identified inconnection evaluation required paragraph dof exchange act rulesa occurred recent fiscal quarter materially affected arereasonably likely materially affect internal control financial reporting itemb other information not applicable part iii item directors executive officers corporate governance information directors incorporated reference discussion itemof proxy statement annual meeting stockholders proxy statement underthe heading election directors information compliance section theexchange act incorporated reference discussion heading section abeneficial ownership compliance proxy statement information audit committeeincluding members committee audit committee table contents mckesson corporation financial expert incorporated reference discussion headings auditcommittee report audit committee financial expert proxy statement the balance ofthe information required item contained discussion entitled executive officersof registrant item parti annual report form pursuant sectiona aof nyse listed company manual companys chiefexecutive officer submitted certification dated august stating datehe aware violation company nyse corporate governance listingstandards information code ethics governing chief executive officer chief financialofficer controller financial managers found web site wwwmckessoncom governance tab the companys corporate governance guidelines charters auditand compensation committees committee directors corporate governance also befound web site governance tab copies documents may obtained corporate secretary mckesson corporation one post street rd floor san francisco ca thecompany intends disclose required information regarding anyamendment waiver code ethics referred byposting information web site within four business daysafter amendment waiver item executive compensation information respect item incorporated reference proxy statement item security ownership certain beneficial owners management relatedstockholder matters information security ownership certain beneficial owners management isincorporated reference proxy statement table contents mckesson corporation the following table sets forth information march respect plansunder companys common stock authorized issuance number securities remaining available future issuance number securities equity issued upon weighted average compensation plans exercise exercise price excluding securities plan category outstanding options outstanding options reflected first in millions except per share amounts warrants rights warrants rights column equity compensation plansapproved securityholders equity compensation plans approvedby security holders includes stock purchase plan employee stock purchase plan esppalso includes options outstanding stock option restricted stock plan whichexpired october stock plan non employee directors equitycompensation deferral plan replaced stock plan following itsapproval stockholders july includes shares remained available purchase espp march includes executive stock purchase plan small assumed sharesave scheme similarto espp united kingdom also includes options remain outstanding theterminated broad based stock option restricted stock plan canadian stockincentive plan two stock option plans replaced stock planfollowing approval stockholders july as result acquisitions company currently assumed option plans whichoptions exercisable shares company common stock no awards willbe made assumed plans information regarding assumed options notincluded table the following descriptions equity plans approved companysstockholders the plans administered compensation committee board directorsexcept portion stock plan related non employee directors isadministered committee directors corporate governance stock plan stock plan the stock plan adopted board ofdirectors may approved companys stockholders july the stock plan provides grant million shares form nonqualified stockoptions incentive stock options stock appreciation rights restricted stock awards restrictedstock unit awards performance shares share based awards for one share commonstock issued connection stock settled stock appreciation right restricted stock awardrestricted stock unit award performance share share based award two shares shall bededucted shares available future grants shares common stock issued ordelivered result net exercise stock appreciation right option shares used topay withholding taxes related stock award shares repurchased open market withproceeds exercise options shall returned reserve shares available forissuance stock plan options granted less fair market value term seven yearsoptions generally become exercisable four equal annual installments beginning one year thegrant date four years date grant the award vesting restricted stockrestricted stock units rsus performance based rsus may conditioned upon attainment ofone performance objectives vesting awards generally three year cliff non employee directors receive annual grant rsus currently set rsus vest immediately however payment shares delayed director nolonger performing services company the stock plan replaced non employeedirectors equity compensation deferral plan stock purchase plan spp the spp adopted stockholders companyspredecessor the companys stockholders approved additional million shares beissued spp remain available issuance rights purchase shares aregranted spp key employees company determined compensation committeeof board the purchase price paid cash using promissory notes companyscommon stock subject rights granted spp fair market value stock onthe date right exercised table contents mckesson corporation employee stock purchase plan espp the espp intended qualify anemployee stock purchase plan within meaning section internal revenue code inmarch board amended espp allow participation plan employees ofcertain companys international subsidiaries as employees esppdoes qualify currently million shares authorized issuance theespp the espp implemented continuous series three month purchase periods purchaseperiods contributions made toward purchase common stock theplan each eligible employee may elect authorize regular payroll deductions nextsucceeding purchase period amount may exceed participants compensationat end purchase period funds withheld participant used topurchase shares companys common stock the purchase price share companyscommon stock based fair market value share last day theapplicable purchase period in general maximum number shares common stock may bepurchased participant calendar year determined dividing fairmarket value one share common stock offering date the following descriptions equity plans submitted approval bythe companys stockholders on july companys stockholders approved stock plan effectof terminating stock option restricted stock plan canadian stock incentiveplan stock option plans adopted january august plans beensubmitted approval companys stockholders non employee directors equitycompensation deferral plan previously approved companys stockholdersprior grants plans include stock options restricted stock rsus stock optionsunder terminated plans generally ten year life vest four years restrictedstock contains certain restrictions transferability may transferred suchrestrictions lapse each plans outstanding equity grants subject theterms conditions respective plans new grants made theseterminated plans executive stock purchase plan spp the spp adopted board ofdirectors february the spp provided grant rights purchase maximum ofmillion shares common stock subject nyse limits no grants made fromthe spp rights purchase shares granted spp eligible employees ofthe company the purchase price paid cash using promissory notes companyscommon stock subject rights granted spp equal fair market value thecompanys common stock date right exercised closing price thecompanys common stock nyse purchases evidenced written stock purchase agreementswhich provide payment purchase price ipayment cash iia promissorynote payable repayment schedule determined compensation committee board oriiia combination iand ii hboc uk sharesave scheme scheme in connection acquisition thecompany hbo company hboc assumed hboc scheme similar esppunder approximately million shares remain available issuance employees previousdirectors hboc subsidiaries residents united kingdom eligible toreceive options scheme the exercise price stock covered optionshall less fair market value companys common stock date theoption granted participants scheme pay options monthlycontributions subject minimum maximum monthly limits we longer offer new optionsunder scheme itemcertain relationships related transactions directorindependence information respect certain transactions management incorporated referencefrom proxy statement heading certain relationships related transactionsadditional information regarding related party transactions included financial reviewsection annual report form financial note related party balances andtransactions consolidated financial statements table contents mckesson corporation itemprincipal accounting fees services informationregarding principal accounting fees services set forth headingratification appointment deloitte touche llp companys independent registeredpublic accounting firm proxy statement information incorporatedherein reference table contents mckesson corporation part iv item exhibits financial statement schedule financial statements financial statement schedule exhibits page consolidated financial statements report independentregistered public accounting firm see index consolidatedfinancial information supplementary consolidated financial statement schedulevaluation qualifying accounts financial statements schedules included omittedbecause absence conditions required orbecause required information material shown thefinancial statements financial notes supplementary financialinformation exhibits submitted annual report form filed withthe sec incorporated reference filings arelisted exhibitindex table contents mckesson corporation signatures pursuant requirements section securities exchange act registrant duly caused report signed behalf undersigned thereuntoduly authorized mckesson corporation dated may jeffrey campbell jeffrey campbell executive vice president chief financial officer on behalf registrant pursuant requirements securities exchangeact report signed following persons capacities onthe date indicated john hammergren marie knowles director chairman president chief executive officer principal executive officer jeffrey campbell david lawrence md director executive vice president chief financial officer principal financial officer nigel rees robert matschullat director vice president controller principal accounting officer wayne budd director james napier director alton irby iii director jane shaw director laureen seeger christine jacobs director laureen seeger attorney fact dated may table contents mckesson corporation schedule ii supplementary consolidated financial statement schedule valuation and qualifying accounts for years ended march in millions deductions additions from balance charged charged allowance balance beginning costs other accounts end description year expenses accounts year year ended march allowances fordoubtful accounts other allowances year ended march allowances fordoubtful accounts other allowances year ended march allowances fordoubtful accounts other allowances deductions written credited accounts total amounts shown deductions fromreceivables includes amillion recovery previously reserved doubtful account includes amillion allowance non current receivables primarily representsadditions relating acquisitions table contents mckesson corporation exhibit index exhibits identified parentheses file commission incorporatedby reference exhibits hereto exhibit number description certificate amendment restated certificate incorporationof company filed delaware secretary state onaugust exhibit companys quarterly report onform quarter ended june file no restated certificate incorporation company filed withthe delaware secretary state november exhibitto companys quarterly report form quarterended june file no amended restated by laws company dated january exhibit companys current report form kdate report january file no indenture dated march company asissuer the first national bank chicago trusteeexhibit companys annual report form thefiscal year ended march file no amended restated declaration trust mckesson financingtrust dated february among company the firstnational bank chicago institutional trustee first chicagoinc delaware trustee regular trustees exhibit toamendment no companys registration statement forms registration no filed june indenture dated january company asissuer bank new york trustee exhibit thecompanys annual report form fiscal year endedmarch file no indenture dated march mckessoncorporation issuer the bank new york trust companyna trustee exhibit companys current report onform date reportfebruary file no letter agreement dated january annex stipulation agreement ofsettlement lead plaintiff defendants mckesson hbocinc hbo company thereto connection theconsolidated securities class action exhibit thecompanys current report form date report january file no mckesson corporation stock option restricted stock planas amended march exhibit companysannual report form fiscal year ended march file no statement terms conditions applicable certain stockoptions granted august exhibit companysannual report form fiscal year ended march file no mckesson corporation non employee directors equitycompensation deferral plan amended january exhibit companys annual report form kfor fiscal year ended march file no mckesson corporation supplemental psip amended restated january exhibit tothe companys annual report form fiscal year endedmarch file no mckesson corporation deferred compensation administration planamended restated effective october exhibit tothe companys annual report form fiscal year endedmarch file no mckesson corporation deferred compensation administration plan iias amended restated effective october exhibitto companys annual report form fiscal yearended march file no mckesson corporation option gain deferral plan amendedand restated effective october exhibit thecompanys annual report form fiscal year endedmarch file no mckesson corporation management deferred compensation planamended restated october exhibit thecompanys annual report form fiscal year endedmarch file no mckesson corporation executive benefit retirement plan amendedand restated october exhibit thecompanys quarterly report form quarter endedseptember file no table contents mckesson corporation exhibit number description mckesson corporation executive survivor benefits plan amendedand restated october exhibit thecompanys annual report form fiscal year endedmarch file no mckesson corporation executive medical plan amended andrestated effective january exhibit thecompanys annual report form fiscal year endedmarch file no mckesson corporation severance policy executive employees asamended restated january exhibit thecompanys quarterly report form quarter endedseptember file no mckesson corporation management incentive plan amendedand restated effective october exhibit tothe companys quarterly report form quarter endedseptember file no mckesson corporation long term incentive plan amended andrestated janurary exhibit companysquarterly report form quarter ended september file no mckesson corporation stock purchase plan amended july exhibit companys annual report form fiscal year ended march file no mckesson corporation executive stock purchase plan exhibit companys registration statement forms registration no filed february statement terms conditions applicable certain stockoptions granted january exhibit thecompanys annual report form fiscal year endedmarch file no form restricted stock unit agreement stock plan exhibit companys annual report form fiscal year ended march file no form stock option grant notice stock plan exhibit companys annual report form fiscal year ended march file no mckesson corporation stock plan amended restated asof may exhibit companys quarterly reporton form quarter ended september file no statement terms conditions applicable restricted stockunits granted outside directors pursuant stockplan effective july exhibit companyscurrent report form date report july file no statement terms conditions applicable optionsrestricted stock restricted stock units performance sharesgranted employees pursuant stock plan effectiveapril exhibit companys annual report form fiscal year ended march file no deed settlement amendment relation human resourcesand payroll services contract dated june betweenthe secretary state health united kingdom andmckesson information solutions uk limited confidentialtreatment granted certain portions exhibitand confidential portions filed commission exhibit companysquarterly report form period ended june file no amended restated receivablespurchase agreement dated ofjune among company servicer cgsf fundingcorporation seller several conduit purchasers timeto time party agreement several committed purchasersfrom time time party agreement several managingagents time time party agreement bank onena main office chicago collateral agent exhibit tothe companys annual report form fiscal year endedmarch file no credit agreement dated ofseptember among mckessoncorporation mckesson canada corporation bank america na asadministrative agent bank america na acting itscanada branch canadian administrative agent respect tothe canadian loans bankers acceptance facility wachoviabank national association lc issuer lender fromtime time party thereto exhibit companys currentreport form date report september file no purchase agreement dated ofdecember mckessoncapital corp general electric capital corporation exhibit companys annual report form fiscalyear ended march file no table contents mckesson corporation exhibit number description services agreement dated ofdecember mckessoncapital corp general electric capital corporation exhibit companys annual report form fiscalyear ended march file no interim credit agreement dated january amongmckesson corporation bank america na administrativeagent wachovia bank national association syndication agentthe lenders party thereto banc america securitiesllc wachovia capital markets llc joint lead arrangers andjoint book managers exhibit companys current reporton form date report january file no employment agreement dated november betweenthe company chairman president chief executiveofficer exhibit companys quarterly report form quarter ended september file no employment agreement dated november betweenthe company executive vice president presidentprovider technologies exhibit companys quarterlyreport form quarter ended december fileno employment agreement dated november betweenthe company executive vice president group presidentexhibit companys quarterly report form forthe quarter ended december file no mckesson corporation change control policy selectedexecutive employees effective november exhibit companys quarterly report form thequarter ended september file no mckesson corporation deferred compensation administration plandcap iii effective january exhibit tothe companys quarterly report form quarter endedseptember file no statement terms conditions applicable officers pursuantto stock plan exhibit companys currentreport form date report may file no statement terms conditions applicable chiefexecutive officer pursuant stock plan exhibit tothe companys current report form date report may file no calculation ratio earnings fixed charges list subsidiaries registrant consent independent registeredpublic accounting firm deloitte touche llp power attorney certification chief executive officer pursuant rulea ruled securities exchange act asadopted pursuant section sarbanes oxley act certification chief financial officer pursuant rulea ruled thesecurities exchange act adopted pursuant section thesarbanes oxley act certification pursuant usc section adoptedpursuant section sarbanes oxley act managementcontract compensation plan arrangement directorsandor executive officers eligible participate registrant agrees furnish commission upon request copy instrument definingthe rights security holders respect issues long term debt registrant theauthorized principal amount exceed total assets registrant table contents mckesson corporation index to consolidated financial information page five year highlights financial review managements annual report internal control over financial reporting report independent registered public accounting firm consolidated financial statements consolidated statements operations years ended march consolidated balance sheets march consolidated statements stockholders equity years ended march consolidated statements cash flows years ended march financial notes table contents mckesson corporation five year highlights as years ended march in millions except per share amounts ratios operating results revenues percent change gross profit income lossfrom continuing operations incometaxes income lossafter income taxes continuing operations discontinued operations net income loss financial position working capital days sales outstanding customer receivables inventories drafts accounts payable total assets total debt including capital lease obligations stockholders equity property acquisitions acquisitions businesses net common share information common shares outstanding year end shares earnings lossper common share werebased diluted basic diluted earnings lossper common share continuing operations discontinued operations total cash dividends declared cash dividends declared per common share book value per common share market value per common share year end supplemental data capital employed debt capital ratio net debt net capital employed average stockholders equity return stockholders equity footnotes five year highlights based year end balances sales cost sales last days year dayssales outstanding customer receivables adjusted include accounts receivable sold certain computations may reflect rounding adjustments represents stockholders equity divided year end common shares outstanding consists total debt stockholders equity ratio computed total debt divided capital employed ratio computed total debt net cash cash equivalents net debt divided bynet debt stockholders equity net capital employed represents five quarter average stockholders equity ratio computed net income loss divided five quarter average stockholdersequity table contents mckesson corporation financial review item managements discussion analysis results operations financialcondition general managements discussion analysis results operations financial conditionreferred financial review intended assist reader understanding andassessment significant changes trends related results operations financialposition company together subsidiaries this discussion analysis beread conjunction consolidated financial statements accompanying financial notesthe companys fiscal year begins april ends march unless otherwise noted allreferences document particular year shall mean companys fiscal year we conduct business three operating segments pharmaceutical solutionsmedical surgical solutions provider technologies see financial note accompanyingconsolidated financial statements significant accounting policies description thesesegments results of operations overview years ended march in millions except per share data revenues securities litigation credit charge net income loss continuing operationsbefore income taxes discontinued operations net net income loss diluted earnings loss per share revenues increased billion billion theincrease revenues primarily reflects growth pharmaceutical solutions segment whichaccounted consolidated revenues increases revenue segment wereprimarily due market growth rates due acquisition dk healthcare resources incdk second quarter gross profit increased billion billion as apercentage revenues gross profit increased basis points bp bp our gross profit includes receipt million million million cash proceeds representing share settlements antitrust classaction lawsuits excluding settlements gross profit margin increased bp bp the increase gross profit margin primarily reflects improvement inmargins us pharmaceutical distribution business operating expenses billion billion billion operating expenses includes pre tax credit million pre taxcharges million billion securities litigation excluding securitieslitigation charges credit operating expenses increased primarilyreflecting additional operating expenses incurred support sales growth highercompensation expenses including expenses associated implementation statement offinancial accounting standards sfas nor share based compensation sfas norwas implemented april requires us expense share based compensationoperating expenses also impacted business acquisitions including acquisition ofdk other income net approximated other income net increased million primarily reflecting increases interest income due favorable cashbalances table contents mckesson corporation financial review continued interest expense increased million decreased million interest expense increased primarily reflecting issuance billion debt aspart billion acquisition per se technologies inc per se interest expensedecreased primarily reflecting repayment million term debt fourthquarter income lossfrom continuing operations income taxes million million million reflecting noted factors our reported income tax rates fluctuations reported income tax rates primarily due changes income within statesand foreign countries lower tax rates additionally recorded millioncredit income tax provision relating reversal income tax reserves oursecurities litigation the tax reserves initially established future resolutionof uncertain tax matters related securities litigation favorably resolved results discontinued operations include tax loss million taxgains million million per diluted share during second quarter sold medical surgical solutions segmentsacute care business net cash proceeds million financial results business reflect tax loss million includes million non tax deductiblewrite goodwill financial results acute care business reclassified adiscontinued operation periods presented net income losswas million million million anddiluted earnings lossper share excluding securitieslitigation charges credit net income would million million million diluted earnings per share would revenues years ended march in millions pharmaceutical solutions us healthcare direct distribution services us healthcare sales customers warehouses subtotal canada distribution services total pharmaceutical solutions medical surgical solutions provider technologies services software software systems hardware total provider technologies total revenues revenues increased billion billion the growthin revenues primarily driven pharmaceutical solutions segment accounted revenues table contents mckesson corporation financial review continued the customer mix us pharmaceutical distribution revenues follows direct sales independents retail chains institutions subtotal sales customers warehouses total us healthcare pharmaceutical direct distribution service revenues increased primarily reflecting market growth rates partially offset loss large customerrevenues also impacted acquisition dk second quarter expanded agreements customers revenues segment increased primarilydue acquisition dk growth among existing customers includes market growthrates market growth rates reflect growing drug utilization price increases offsetin part increased use lower priced generics us healthcare sales customers warehouses increased last two years primarily asa result new expanded agreements customers partially offsetting increases adecrease volume large customer commencing sales customers warehousesrepresent large volume sales pharmaceuticals primarily limited number largeself warehousing customers whereby order bulk product manufacturer receive processthe product central distribution facility subsequently deliver bulk productgenerally form received manufacturer directly customerswarehouses these sales provide benefit customers use one source forboth direct store store business warehouse business we significantlylower gross profit margin sales pass much theefficiency lowcost serve model onto customer these sales however contribute gross profitdollars canadian pharmaceutical distribution revenues increased last two yearsprimarily reflectingmarket growth rates favorable exchange rates canadian revenues benefited foreign currency impact medical surgical solutions segment distribution revenues increased primarilyreflecting stronger average market growth rates due acquisition sterling medicalservices llc sterling first quarter sterling based moorestown newjersey national provider distributor disposable medical supplies healthmanagement services quality management programs home care market this segmentsrevenues also increased primarily due market growth rates provider technologies revenues increased last two years primarily reflecting greaterdomestic implementations clinical imaging revenue cycle resource management softwaresolutions in revenues segment also benefited increased software solutionimplementations lesser extent due acquisition per se fourth quarterof table contents mckesson corporation financial review continued gross profit years ended march dollars millions gross profit pharmaceutical solutions medical surgical solutions provider technologies total gross profit margin pharmaceutical solutions medical surgical solutions provider technologies total gross profit increased billion billion as apercentage revenues gross profit increased bp bp all three ouroperating segments contributed increase gross profit dollars gross profit marginin increases gross profit dollars primarily due pharmaceuticalsolutions segment lesser extent due provider technologies segment gross profitmargins increased primarily due increase pharmaceutical solutions segmentsgross profit margin our pharmaceutical solutions segments gross profit margin improved past two yearsthis segments gross profit margin impacted number changes including higher buy side margins our buy side margins reflect changes distributionarrangements us pharmaceutical manufacturers manufacturers over past years us pharmaceutical distribution business changed iscompensated logistical capital administrative services provides brandedpharmaceutical manufacturers historically significant portion compensation themanufacturers inflation based we purchased held pharmaceutical inventory inanticipation manufacturers increasing prices we benefited manufacturersincreased prices sold inventory held new higher prices commencingin branded pharmaceutical manufacturers implemented number changes asrestricting volume product available purchase pharmaceutical wholesalers thesechanges limited ability purchase inventory advance price increases led tovolatility gross profit in manufacturers also reduced number averagemagnitude price increases by early revised distribution arrangements manufacturersunder new arrangements significant portion compensation manufacturersis generated based percentage purchases result longer dependentupon pharmaceutical price increases we continue certain distribution arrangements withmanufacturers include inflation based compensation component otherarrangements remain structured historical inflation based compensation model forthese manufacturers reduction frequency magnitude price increases well asrestrictions amount inventory available us could adversely impact gross profitmargin in benefited certain branded manufacturers price increases selecteddrugs in addition transition new arrangements purchases certain manufacturersare better aligned customer demand result net financial inventory inventory netof accounts payable decreased this decrease positive impact cash flowfrom operations these new arrangements also somewhat diminished seasonality grossprofit margin historically reflected pattern manufacturers price increases table contents mckesson corporation financial review continued benefit increased sales generic drugs higher margins antitrust settlements million compared million million representing share cash proceeds settlements various antitrust class action lawsuits last first lifo inventory credits million compared million million lifo credits reflect number generic productlaunches partially offset higher level brandedpharmaceutical price increases our pharmaceutical solutions segment uses lifo method accounting majority itsinventories results cost sales closely reflects replacement cost doother accounting methods thereby mitigating effects inflation deflation operatingprofit the practice pharmaceutical solutions distribution businesses pass ontocustomers published price changes suppliers manufacturers generally provide us priceprotection limits price related inventory losses price declines many genericpharmaceutical products segment last years moderated effects ofinflation product categories resulted minimal overall price changes thoseyears decrease gross profit margin associated agreater proportion revenues within segment attributed tosales customers warehouses lower gross profitmargins relative revenues within segment in gross profit margin positively impacted smallerproportion segment revenues attributed sales customerswarehouses million charge pertaining write ofcertain abandoned assets within retail automation groupduring first quarter contributed million incash million net assets primarily automatedprescription systems business parata systems llc paratain exchange significant minority interest parata paratais manufacturer pharmacy robotic equipment in connectionwith investment abandoned certain assets resulted ina million charge cost sales incurred millionof expenses related transaction recordedwithin operating expenses we recognize additionalgains losses result transaction believe thefair value investment parata determined athird party valuation approximates carrying value ofconsideration contributed parata our investment parata isaccounted equity method accounting within ourpharmaceutical solutions segment benefit higher supplier cash discounts achange customer mix higher sales volume in addition gross profit margin us pharmaceutical distribution business benefitedfrom relatively stable sell side margin last two years medical surgical solutions segments gross profit margin increased primarilyreflecting favorable product mix buy sell side margins this segments gross profit margindecreased primarily reflecting pressure buy sell margins provider technologiessegments gross profit margin increased primarily due change product mix thissegments gross profit margin approximated table contents mckesson corporation financial review continued operating expenses years ended march dollars millions operating expenses pharmaceutical solutions medical surgical solutions provider technologies corporate subtotal securities litigation charge credit net total operating expenses percentage revenues pharmaceutical solutions medical surgical solutions provider technologies total operating expenses increased billion decreased billion operating expenses include pre tax credit million andpre tax charges million billion securities litigation excluding theimpact securities litigation operating expenses increased operating expenses percentage revenues increased bp decreased bp bp bp excluding impact securitieslitigation excluding securities litigation charges credit increases operatingexpenses compared primarily due additional costs support salesvolume growth business acquisitions employee compensation costs including requirement toexpense share based compensation research development expenditures increases inoperating expenses compared excluding securities litigation charges wereprimarily due additional expenses incurred support sales volume growth includingdistribution expenses higher foreign currency exchange rates canadian operations andincreased research development expenditures operating expenses also impacted byour acquisition dk operating expenses included following significant items million share based compensation expense millionmore previous year on april adopted sfasnor requires recognition expense resultingfrom transactions acquire goods services byissuing shares share options equity instrumentsthe incremental compensation expense recorded follows million million million pharmaceuticalsolutions medical surgical solutions provider technologiessegments million corporate expenses million restructuring expenses primarily severance torealign certain businesses functions theserestructuring charges incurred follows million ourpharmaceutical solutions segment million providertechnologies segment million credit pharmaceutical solutions operatingexpenses due favorable adjustment legal reserve million net charge securities litigation adecrease legal expenses associated litigation whichwere recorded corporate expenses million credit pharmaceutical solutions bad debtexpense due recovery previously reserved customeraccount table contents mckesson corporation financial review continued billion charge securities litigation anincrease legal expenses associated litigation whichwere recorded corporate expenses approximately million settlement charges pertaining anon qualified pension plan primarily included incorporate expenses in made several lump sum cashpayments totaling approximately million unfunded uspension plan in accordance accounting standards additionalcharges settlements associated lump sum payments ofpension obligations expensed period thepayments made other income net years ended march in millions by segment pharmaceutical solutions medical surgical solutions provider technologies corporate total other income net decreased increased primarily reflecting changes ourinterest income associated companys cash balances lesser extent dueto increase equity earnings nadro sa de cv nadro interest income whichis primarily recorded corporate expenses million million million segment operating profit corporate expenses years ended march dollars millions segment operating profit pharmaceutical solutions medical surgical solutions provider technologies subtotal corporate expenses net securities litigation credit charge net interest expense income loss continuing operationsbefore income taxes segment operating profit margin pharmaceutical solutions medical surgical solutions provider technologies segment operating profit includes gross margin net operating expenses incomefor three business segments in addition significant items previously discussedoperating profit increased primarily reflecting revenue growth increase ingross profit margin pharmaceutical solutions segment improved operating profitin provider technologies segment operating profit percentage revenues increased pharmaceuticalsolutions segment primarily reflecting increase gross profit margins offset part anincrease operating expenses percentage revenues operating expenses increased bothdollars percentage revenues primarily due additional costs incurred support ourrevenue growth additional compensation expense addition dks operating andintegration expenses in operating profit segment also benefited million credit operating expense due adjustment legal reserve thesegment table contents mckesson corporation financial review continued benefited million credit bad debt expense due recovery previouslyreserved customer account operating profit also benefited increase equityearnings investment nadro medical surgical solutions segments operating profit percentage revenues declined primarily reflecting increase operating expenses percentage revenues partiallyoffset small improvement segments gross profit margin the segments operating profitas percentage revenues also declined primarily reflecting lower gross profit marginpartially offset decrease operating expenses percentage revenues over pasttwo years operating expenses percentage revenue impacted higher amount ofoperating costs associated greater proportion costs incurred serve segmentsalternate site customers higher cost serve ratio segments othercustomers additionally operating expenses include increases compensation expense andin increase bad debt expense operating expenses also benefited froma receipt vendor credit decrease legal expenses provider technologies segments operating profit percentage revenues decreased primarily reflecting increase operating expenses percentage revenues partiallyoffset increase gross profit margin operating expenses increased dollars asa percentage revenues primarily reflecting additional compensation expense andrestructuring charges incurred reallocate product development marketing resources torealign one segments international businesses this segments operating profit apercentage revenues increased primarily reflecting favorable operating expenses apercentage revenues in addition factors previously noted operating expense dollars forthis segment increased past two years reflecting investments research developmentactivities sales functions support segments revenue growth business acquisitionsadditionally operating expenses benefited reduction bad debt expense thissegment process completing business integrationplans theacquisition per se in accordance accounting standards certain costs beincurred integrate acquired businesses treated part cost acquisitionwhereas related costs expensed corporate expenses net income increased primarily reflecting additionalcosts incurred support various initiatives revenue growth increase compensationexpense decrease interest income legal costs associated securities litigationdeclined however legal costs offset benefit corporate expenses net otherincome decreased primarily reflecting increase interest income decrease legalcosts associated securities litigation decrease pension settlement chargesthese favorable variances partially offset additional costs incurred support variousinitiatives revenue growth legal costs associated securities litigation million million million securities litigation charges net as discussed financial note other commitments andcontingent liabilities accompanying consolidated financial statements thirdquarter announced reached agreement settle action captioned in remckesson hboc inc securities litigation noc rmw consolidated action ingeneral agreed pay settlement class total million cash during thirdquarter recorded million pre tax million tax charge respectto companys securities litigation the charge consisted million consolidatedaction million securities litigation proceedings during settled many securities litigation proceedings paid million pursuant settlements based payments made consolidated action andthe securities litigation proceedings settlements reached certain securitieslitigation proceedings assessment remaining cases estimated reserves wereincreased million million pre tax charges first third quarters decreased million pre tax credit fourth quarter totalnet pre tax charge million on february court gave final approval tothe settlement consolidated action result paid approximately million intoan escrow account established lead plaintiff connection settlement during securities litigation accrual decreased million primarily reflecting anet pre tax credit million representing settlement reassessment another case inthe second quarter million cash payments made connection thesesettlements based payments made table contents mckesson corporation financial review continued consolidated action payments made settleother previously reported securities litigation proceedings andbased assessment remaining cases estimated securities litigation accrualsas march million million we believe accrual isadequate address remaining potential exposure respect securitieslitigation matters however view number uncertainties timing outcome ofthis type litigation substantial amounts involved possible ultimatecosts matters could impact earnings either negatively positively quarterof resolution we believe resolution matters materialadverse effect results operations liquidity financial position taken whole interest expense interest expense increased compared primarily due billion additional financing required fund acquisition per se refer ourdiscussion caption credit resources within financial review additionalinformation regarding financing per se acquisition interest expense decreased compared primarily reflecting repayment million term debt fourthquarter income taxes our reported tax rates inaddition items noted fluctuations reported tax rate primarily due tochanges within state foreign tax rates resulting business mix including varyingproportions income attributable foreign countries lower income tax rates securities litigation as discussed financial note income taxes recorded anincome tax benefit million relating securities litigation third quarter we believed pending settlement consolidated action ultimate resolution ofthe lawsuits brought independently shareholders would tax deductible however taxattributes litigation complex company expected challenges taxingauthorities accordingly deductions could finalized lawsuits wereconcluded tax authorities reviewed deductions as march provided taxreserves future resolution uncertain tax matters in second quarter recorded credit income tax expense million whichprimarily pertains receipt private letter ruling us internal revenue serviceholding payment approximately million settle securities litigationconsolidated action fully tax deductible as discussed preceding paragraph wepreviously established tax reserves reflect lack certainty regarding taxdeductibility settlement amounts paid consolidated action related litigation other income tax adjustments in recorded million income tax benefitsarising primarily settlements adjustments various taxing authorities research anddevelopment investment tax credits generated canadian operations in recorded million income tax expense primarily relates basisadjustment investment adjustments various taxing authorities in recorded million income tax benefit arising primarily settlements andadjustments various taxing authorities million income tax benefit primarily due areduction valuation allowance related state income tax net operating loss carryforwardswe believe income tax benefit portion state net operating losscarryforwards realized table contents mckesson corporation financial review continued discontinued operations results discontinued operations follows years ended march in millions income lossfrom discontinued operations acute care bioservices other income taxes total gain losson sales discontinued operations acute care bioservices other income taxes total discontinued operations net taxes acute care bioservices other total in second quarter sold medical surgical solutions segments acute caresupply business owens minor inc omi net cash proceeds approximately millionin accordance sfas no accounting impairment disposal long lived assetsthe financial results business classified discontinued operation periodspresented accompanying consolidated financial statements revenues associated theacute care business prior disposition million million million first half financial results discontinued operation include tax loss million primarily consists tax loss million business dispositionand million tax losses associated operations asset impairment charges andemployee severance costs the tax loss million business disposition includesa million non tax deductible write goodwill described in connection divestiture acute care business allocated portion ourmedical surgical solutions segments goodwill acute care business required sfas no goodwill other intangible assets the allocation based relative fair valuesof acute care business continuing businesses retained companythe fair value acute care business determined based net cash proceeds resultingfrom divestiture fair value continuing businesses determined athird party valuation as result allocated million segments goodwill theacute care business additionally part divestiture entered transition services agreementtsa omi provided certain services acute care business atransition period approximately six months financial results tsa well employeeseverance charges transition period recorded part discontinued operationsthe continuing cash flows generated tsa material consolidated financialstatements tsa completed march table contents mckesson corporation financial review continued in acute care business entered agreement third party vendor sellthe vendors proprietary software services the terms contract required us prepaycertain royalties during third quarter ended marketing sale softwareunder contract as result decision recorded million pre tax charge thethird quarter write remaining balance prepaid royalties in second quarter also sold wholly owned subsidiary pharmaceutical buyersinc net cash proceeds million the divestiture resulted tax gain million resulting tax basis subsidiary exceeding carrying value the gain ondisposition also recorded second quarter financial results businesswhich previously included pharmaceutical solutions segment material ourconsolidated financial statements the results discontinued operations also include tax gain millionassociated collection note receivable business sold sale asmall business in second quarter sold wholly owned subsidiary mckesson bioservicescorporation bioservices net cash proceeds million the divestiture resulted anafter tax gain million financial results business previously includedin pharmaceutical solutions segment material consolidated financialstatements in accordance sfas no financial results businesses classified asdiscontinued operations periods presented net income net income losswas million million million diluted earnings lossper share excluding thesecurities litigation charges net income net income per diluted share would beenmillion million million reconciliation net income lossper share reported accounting standardsgenerally accepted gaap united states earnings per diluted share excludingcharges securities litigation follows years ended march in millions except per share amounts net income loss reported exclude securities litigation charge credit net estimated income tax expense benefit income tax reserve reversal securities litigation charge net tax net income excluding securities litigation charge diluted earnings per common share excludingsecurities litigation charge shares diluted earnings per commonshare excluding securities litigationcharge based for interest expense net related income taxes million million added net income excluding securities litigation charges forpurpose calculating diluted earnings per share this calculation also includes impactof dilutive securities stock options convertible junior subordinated debentures andrestricted stock these pro forma amounts non gaap financial measures we use measuresinternally consider results useful investors provide relevant benchmarksof core operating performance table contents mckesson corporation financial review continued weighted average diluted shares outstanding diluted earnings lossper share calculatedbased weighted average number shares outstanding million million million weighted average shares outstanding decreased primarily reflecting common stock repurchased year net stock option exercisesweighted average diluted shares outstanding primarily reflect increase number ofcommon shares outstanding result exercised stock options net common stock repurchasedas well increase common stock equivalents stock options due increase inthe companys common stock price for potentially dilutive securities excluded theper share computations due antidilutive effect international operations international operations accounted consolidatedrevenues international operations subject certain risks including currency fluctuationswe monitor operations adopt strategies responsive changes economic politicalenvironment countries operate additional information regarding ourinternational operations also included financial note segments business theaccompanying consolidated financial statements acquisitions investments in made following acquisitions investment on january acquired outstanding shares per se alpharetta georgia pershare cash plus assumption per ses debt orapproximately billion aggregate including cashacquired million per se leading provider offinancial administrative healthcare solutions forhospitals physicians retail pharmacies theacquisition initially funded cash hand andthrough use interim credit facility in march issued billion long term debt netproceeds offering expenses issuance togetherwith cash hand used fully repay borrowingsoutstanding interim credit facility refer tofinancial note long term debt other financing approximately million preliminary purchase price allocation assigned togoodwill included purchase price allocation acquired identifiable intangibles ofmillion representing customer relationships weighted average life yearsdeveloped technology million weighted average life years trademark andtradenames million weighted average life years in accordance accounting standards certain costs incurredto integrate acquired businesses treated part cost acquisition whereasother related costs expensed financial results per se primarily includedwithin provider technologies segment since date acquisition our provider technologies segment acquired relayhealth corporationrelayhealth based emeryville california relayhealth aprovider secure online healthcare communication serviceslinking patients healthcare professionals payors pharmaciesthis segment also acquired two entities one specializingin patient billing solutions designed simplify enhancehealthcare providers financial interactions patientsand provider integrated software electronic healthrecords medical billing appointment scheduling forindependent physician practices the total cost threeentities million paid cash goodwillrecognized transactions amounted million our medical surgical solutions segment acquired sterling based inmoorestown new jersey sterling national provider anddistributor disposable medical supplies health managementservices quality management programs home care marketthis segment also acquired leading medical supply sourcingagent the total cost two entities millionwhich paid cash goodwill recognized transactionsamounted million table contents mckesson corporation financial review continued we invested million cash million net assetsprimarily automated prescription systems business inparata exchange significant minority interest parataparata manufacturer ofpharmacy robotic equipment in connection investment abandoned certain assets resulted million chargeto cost sales incurred million expenses related transaction recorded within operatingexpenses we recognize additional gains losses result transaction believe fair value ourinvestment parata determined third party valuation approximates carrying value consideration contributed toparata our investment parata accounted equity method accounting within pharmaceutical solutionssegment in made following acquisitions we acquired substantially issued outstanding stock dk st louis missouri anaggregate cash purchase price million including assumption dks debt dk primarily awholesale distributor branded generic pharmaceuticals counter health beautyproducts independent regional pharmacies primarily midwest approximately million ofthe purchase price assigned goodwill included purchase price acquired identifiableintangibles million primarily representing customer lists compete covenants havean estimated weighted average useful life nine years results dks operations included ourpharmaceutical solutions segment we acquired issued outstanding shares medcon ltd medcon israeli company foran aggregate purchase price million medcon provides web based cardiac image informationmanagement services healthcare providers approximately million purchase price assignedto goodwill million assigned intangibles represent technology assets customerlists estimated weighted average useful life four years the results medconsoperations included provider technologiessegment in made following acquisition investment we invested million increase ownership percentage nadro approximately prior theadditional investment company owned approximately outstanding common shares nadro ourinvestment nadro accounted equity method accounting within pharmaceuticalsolutions segment we acquired issued outstanding shares moore medical corp mmc new britainconnecticut aggregate cash purchase price million mmc internet enabledmulti channel marketer distributor medical surgical pharmaceutical products non hospitalprovider settings approximately million purchase price assigned goodwill the resultsof mmcs operations included consolidated financial statements within ourmedical surgical solutions segment since acquisition date during last three years also completed number smaller acquisitions andinvestments within three operating segments financial results businessacquisitions included consolidated financial statements since respectiveacquisition dates purchase prices business acquisitions allocated based onestimated fair values date acquisition certain recent acquisitions may besubject change goodwill recognized business acquisitions expected bedeductible tax purposes pro forma results operations business acquisitions havenot presented effects material consolidated financial statementson either individual aggregate basis refer financial note acquisitions andinvestments accompanying consolidated financial statements discussionsregarding acquisitions investing activities outlook information regarding companys outlook contained form dated may this form read conjunction sections factors affectingforward looking statements additional factors that may affect future results included inthis financial review table contents mckesson corporation financial review continued operating segments beginningwith first quarter report operations twosegments mckessondistribution solutions mckesson technology solutions this change resulted realignment ourbusinesses better correlate operations needs customers the factors fordetermining reportable segments included manner management evaluated theperformance company combined nature individual business activities inaccordance sfas disclosures segments enterprise related informationall prior period segment information reclassified conform new financialreporting presentation commencing additional information regarding new segments asfollows we combined pharmaceutical solutions medical surgical solutions segments anew segment mckesson distribution solutions this segment distributes ethical proprietarydrugs medical surgical supplies equipment health beauty care products throughoutnorth america this segment also provides specialty pharmaceutical solutions biotech andpharmaceutical manufacturers software consulting outsourcing services itsinvestment parata sells automated pharmaceutical dispensing systems retail pharmacies the mckesson technology solutions segment currently known provider technologiessegment delivers enterprise wide patient care clinical financial supply chain strategicmanagement software solutions pharmacy automation hospitals well connectivityoutsourcing services healthcare organizations throughout north america unitedkingdom european countries the segment also provides disease management programs topayors primarily united states the segments customers include hospitals physicianshomecare providers retail pharmacies payors we added payor group businesseswhich includes clinical auditing compliance disease management medical management andinterqual businesses segment the payor group previously included ourpharmaceutical solutions segment critical accounting policies and estimates we consider accounting estimate critical estimate requires us makeassumptions matters uncertain time accounting estimate made ifdifferent estimates reasonably could used current period changes theaccounting estimate reasonably likely occur period period would amaterial impact financial condition results operations below estimatesthat believe critical understanding operating results financial conditionother accounting policies described financial note significant accounting policies tothe accompanying consolidated financial statements because uncertainty inherent suchestimates actual results may differ estimates receivables we provide short term credit customer financing arrangements tocustomers purchase products services other customer financing relates guaranteesprovided customers creditors regarding repurchase inventories leaseand credit financing we estimate receivables expect full collection basedon historical collection rates specific knowledge regarding current creditworthiness ourcustomers an allowance recorded consolidated financial statements amounts if frequency severity customer defaults due customers financial conditionor general economic conditions change allowance uncollectible accounts may requireadjustment as result continuously monitor outstanding receivables customerfinancing adjust allowances accounts collection may doubt in addition sales ten largest customers accounted approximately total consolidatedrevenues sales largest customer caremark rx inc represented approximately total consolidated revenues at march accounts receivable ten largestcustomers caremark rx inc approximately total accounts receivable as aresult sales credit concentration significant any defaults payment materialreduction purchases large customer could significant negativeimpact financial condition results operations liquidity table contents mckesson corporation financial review continued at march trade notes receivables million customerfinancing million prior allowances million in ourprovision bad debts millionmillion million at march allowance percentage oftrade notes receivables additional information concerning allowance fordoubtful accounts may found scheduleii included annual report form inventories we state inventories lower cost market inventories ourpharmaceutical solutions medical surgical solutions segments consist merchandise held forresale for pharmaceutical solutions segment majority cost domestic inventorieswas determined lifo method international inventories stated using first infirst fifo method cost inventories medical surgical solutions segment wasprimarily determined fifo method provider technologies inventories consist computerhardware cost determined standard cost method totalinventories billion billion march the lifo method used value approximately inventories march if fifo method approximates replacement cost applied total inventorieswould increased million million march in addition werecorded lifo benefit reserve adjustments million million million lifo adjustments generally represent net effect amount price increases onbranded pharmaceutical products held inventory offset price declines genericpharmaceutical products including price decrease effect branded pharmaceutical productsthat lost patent protection lifo benefit implies price declines genericpharmaceutical products including effect branded pharmaceuticals lost patentprotection exceeded effect price increases branded pharmaceutical products held ininventory our remaining pharmaceutical liforeserve approximately million expected used in determining whether inventory valuation issues exist consider various factors includingestimated quantities slow moving inventory reviewing hand quantities outstanding purchaseobligations forecasted sales shifts market trends conditions changes customerpreferences due introduction generic drugs new pharmaceutical products loss ofone significant customers factors could affect value inventoriesthese factors could make estimates inventory valuation differ actual results acquisitions we account acquired businesses using purchase method accountingwhich requires assets acquired liabilities assumed recorded date ofacquisition respective fair values any excess purchase price estimatedfair values net assets acquired recorded goodwill amounts allocated acquiredin process research development expensed date acquisition the judgments made indetermining estimated fair value assigned class assets acquired liabilitiesassumed well asset lives materially impact results operations accordingly forsignificant items typically obtain assistance third party valuation specialists thevaluations based information available near acquisition date based onexpectations assumptions deemed reasonable management there several methods used determine fair value assets acquired andliabilities assumed for intangible assets typically use income method this method startswith forecast expected future net cash flows these cash flows adjustedto present value applying appropriate discount rate reflects risk factors associatedwith cash flow streams some significant estimates assumptions inherent theincome method methods include amount timing projected future cash flows thediscount rate selected measure risks inherent future cash flows assessmentof assets life cycle competitive trends impacting asset including considerationof technical legal regulatory economic barriers entry determining useful life ofan intangible asset also requires judgment different types intangible assets havedifferent useful lives certain assets may even considered indefinite useful lives table contents mckesson corporation financial review continued goodwill we significant goodwill assets result acquiring businesses wemaintain goodwill assets books unless assets deemed impaired we perform animpairment test goodwill balances annually indicators impairment exist suchimpairment tests require first compare carrying value net assets estimatedfair value net assets operations goodwill assigned if carrying valueexceeds fair value second step would performed calculate amount impairment fairvalues determined using market income cost approaches to estimate fair value abusiness using market approach compare business similar businesses guidelinecompanies whose securities actively traded public markets income approach weuse discounted cash flow model cash flows anticipated several periods plus aterminal value end time horizon discounted present value using anappropriate rate return some significant estimates assumptions inherent goodwill impairmentestimation process using market approach include selection appropriate guidelinecompanies determination market value multiples guideline companies subsequentselection appropriate market value multiple business based comparison thebusiness guideline companies determination applicable premiums discounts basedon differences marketability business guideline companies whenconsidering income approach include required rate return used discounted cashflow method reflects capital market conditions specific risks associated thebusiness other estimates inherent income approach include long term growth rates cashflow forecasts business estimates fair value result complex series judgments future events anduncertainties rely heavily estimates assumptions point time the judgments madein determining estimate fair value materially impact results operations thevaluations based information available impairment review date based onexpectations assumptions deemed reasonable management any changes keyassumptions including unanticipated events circumstances may affect accuracy validityof estimates could potentially result impairment charge in september sold medical surgical solutions segments acute care supply businessand allocated million segments goodwill divested business the allocation wasbased relative fair values acute care business continuing businesses wereretained company determined third party valuation goodwill march million million concluded impairment ourgoodwill supplier reserves we establish reserves amounts due suppliers relating tovarious price rebate incentives including deductions billings taken paymentsotherwise due us these reserve estimates established based best judgmentafter carefully considering status current outstanding claims historical experience withthe suppliers specific incentive programs pertinent information available uswe evaluate amounts due suppliers continual basis adjust reserve estimateswhen appropriate based changes factual circumstances as march supplier reserves million millionapproximately supplier reserves atmarch pertains pharmaceutical solutions segment hypothetical percentage increase decrease supplier reserve percentage trade payables wouldhave resulted increase decrease cost sales approximately million the ultimate outcome amounts due suppliers may different estimate income taxes our income tax expense deferred tax assets liabilities reflectmanagements best assessment estimated future taxes paid we subject income taxesin us numerous foreign jurisdictions significant judgments estimates arerequired determining consolidated income tax provision table contents mckesson corporation financial review continued deferred income taxes arise temporary differences tax financial statementrecognition revenue expense in evaluating ability recover deferred tax assetswe consider available positive negative evidence including past operating results theexistence cumulative net operating losses recent years forecast futuretaxable income in estimating future taxable income develop assumptions including amountof future state federal foreign pretax operating income reversal temporary differencesand implementation feasible prudent tax planning strategies these assumptions requiresignificant judgment forecasts future taxable income consistent plansand estimates using manage underlying businesses changes tax laws rates could also affect recorded deferred tax assets liabilitiesin future management aware changes would material effect onthe companys results operations cash flows financial position the calculation tax liabilities involves dealing uncertainties applicationof complex tax regulations multitude jurisdictions across global operations werecognize liabilities based estimate whether additional taxes due theseliabilities recorded despite belief tax return positions supportable webelieve certain positions likely challenged may fully sustained uponaudit tax authorities us countries these tax liabilities reflected netof related tax loss carryforwards we adjust liabilities light changing facts andcircumstances however due complexity uncertainties ultimateresolution may result payment materially different current estimate thetax liabilities these differences reflected increases decreases income taxexpense discrete items period determined if tax liabilitiesrelate tax uncertainties existing date acquisition business adjustmentof tax liabilities result adjustment goodwill recorded date ofacquisition if assumptions estimates described change increasedecrease inour effective tax rate applied income continuing operations would haveincreaseddecreased tax expense approximately million as discussed financial note significant accounting policies caption newaccounting pronouncements first quarter required adopt provisionsof financial interpretation fin no accounting uncertainty income taxes fin no clarifies accounting uncertainty income taxes recognized financial statementsin accordance sfas no accounting income taxes this standard also provides atax benefit uncertain tax position may recognized likely thatthe position sustained upon examination including resolutions related appeals orlitigation processes based technical merits the amount recognized measured thelargest amount tax benefit greater percent likely realized uponultimate settlements this interpretation also provides guidance measurement derecognitionclassification interest penalties accounting interim periods disclosure transitionwhile assessing impact fin no consolidated financial statements wecurrently estimate cumulative effect upon adoption fin no may result decrease toshareholders equity million the estimated impact subject revision wecomplete analysis we continue classify interest penalties paid anunderpayment income taxes income taxes consolidated statements operations share based payment our compensation programs include share based payments beginning account share based payment transactions using fair value based measurementmethod required sfas nor share based payment we adopted sfas nor using themodified prospective method transition the share based compensation expense recognized forthe portion awards ultimately expected vest straight line basis therequisite service period awards graded vesting service conditions for theawards performance conditions recognize expense straight line basis treatingeach vesting tranche separate award upon adoption sfas nor first quarterof elected short cut method calculating beginning balance additionalpaid capital pool related tax effects share based compensation table contents mckesson corporation financial review continued we estimate grant date fair value employee stock options using black scholesoption pricing model we believe difficult accurately measure value anemployee stock option our estimates employee stock option values rely estimates factorswe input model the key factors involve estimate future uncertain events the keyfactors influencing estimation process among others expected term option theexpected stock price volatility factor expected dividend yield we continue usehistorical exercise patterns best estimate future exercise patterns determining ourexpected term option we use combination historical quoted implied volatility todetermine expected stock price volatility factor we believe market based inputprovides better estimate future stock price movements consistent emergingemployee stock option valuation considerations our expected stock price volatility assumptioncontinues reflect constant dividend yield expected term option once thefair values employee stock options determined current accounting practices permitthem changed even estimates used different actual in addition develop estimate number share based awards ultimatelyvest primarily based historical experiences changes estimated forfeiture rate havea material effect share based compensation expense if actual forfeiture rate higherthan estimated forfeiture rate adjustment made increase estimated forfeiturerate result decrease expense recognized financial statements ifthe actual forfeiture rate lower estimated forfeiture rate adjustment madeto decrease estimated forfeiture rate result increase expenserecognized financial statements we assess estimated forfeiture rate establishedupon grant periodically throughout required service period such estimates revised theydiffer materially actual forfeitures as required forfeiture estimates adjustedto reflect actual forfeitures award vests the actual forfeitures future reportingperiods could materially higher lower current estimates our assessments estimated share based compensation charges affected stock priceas well assumptions regarding number complex subjective variables related taximpact these variables include limited volatility stock priceemployee stock option exercise behaviors timing level types grants annualshare based awards attainment performance goals as result future share basedcompensation expense may differ companys historical amounts in share basedcompensation charges amounted per diluted share approximately per diluted sharemore share based compensation expense recognized net income prior adoption sfas nor accounted employee stock basedcompensation plans using intrinsic value method accounting principles board apbopinion no accounting stock issued employees under policy since exerciseprice stock options granted generally set equal market price date thegrant record expense income statement related grants stockoptions unless certain original grant date terms subsequently modified the pro forma effecton net income lossand diluted earnings lossper common share required disclosureprovisions sfas no accounting stock based compensation amended sfas noaccounting stock based compensation transition disclosure years ended march set forth financial note share based payment loss contingencies we subject various claims pending potential legal actions forproduct liability damages investigations relating governmental laws regulationsand matters arising normal conduct business each significant matter isregularly reviewed assessed potential financial exposure if potential loss isconsidered probable reasonably estimated accrue liability consolidatedfinancial statements the assessment probability estimation amount highly subjectiveand requires significant judgment due uncertainties related matters based thebest information available time the accruals adjusted appropriate additionalinformation becomes available the amount actual loss may differ significantly theseestimates table contents mckesson corporation financial review continued financial condition liquidity and capital resources net cash flow operating activities million compared million million operating activities benefited improvedaccounts receivable management reflecting changes customer mix termination acustomer contract increase accounts payable associated improved payment termsthese benefits partially offset increases inventory needed support growth andtiming inventory receipts cash flows operations significantly impacted factorssuch timing receipts customers payments vendors operating activities also reflect payments million settlements securities litigation cases net cash flow operations increased primarily reflecting improved working capitalbalances us pharmaceutical distribution business purchases certain oursuppliers became better aligned customer demand result net financial inventoryinventory net accounts payable decreased operating activities also benefited frombetter inventory management operating activities include million cash receipt inconnection amended agreement entered customer cash settlement payments ofmillion securities litigation additionally cash flows operations include reduction current income taxes payable reduction deferred tax assetswhich largely pertain securities litigation cash settlementpayments including million placed escrow deducted income tax return net cash flow fromoperating activities includes million non cash million tax charge forthe securities litigation net cash used investing activities million compared millionin million investing activities reflect payments millionfor business acquisitions including billion per se million ourinvestment parata investing activities also reflect million cash proceedsfrom sale businesses including million sale acute care businessinvesting activities include increases property acquisitions capitalized softwareexpenditures primarily reflect investment us pharmaceutical distribution centernetwork provider technologies segments investment software contract thebritish governments national health services information authority organization investingactivities also include million expenditures business acquisitionsincluding dk use cash million due transfer cash escrow account forfuture payment securities litigation partially offsetting increases cashproceeds million pertaining sale bioservices investing activities include million business acquisition primarily mmc andmillion forthe increased investment nadro financing activities provided cash million utilized cash millionand million on march issued million notes due million notes due net proceeds issuance offering expensesof notes million used together cash hand repay billion ofshort term borrowings outstanding interim facility entered connectionwith acquisition per se financing activities also include billion cashpaid stock repurchases partially offset million cash receipts common stockissuances cash received common stock issuances primarily represent employees exercises ofstock options financing activities include million cash paid stockrepurchases million cash paid repayment life insurance policy loans whichwas partially offset million cash receipts common stock issuances financingactivities include repayment million long term debt partially offset million cash receipts common stock issuances cash dividends paid million million million the companys board directors board approved share repurchase plans october august december january permitted company repurchase atotal billion million per plan companys common stock under plans werepurchased million shares million made repurchases as ofmarch less million remained available future repurchases january plan plans completed table contents mckesson corporation financial review continued in april july board approved two new share repurchase plans permitted thecompany repurchase additional billion million per plan companyscommon stock during repurchased total million shares billion as aresult repurchases effectively completed share repurchase plans on april board approved additional share repurchase plan billion companys common stock repurchased shares used support stock based employee compensation plans othergeneral corporate purposes stock repurchases may made time time open market orprivate transactions selected measures liquidity capital resources march dollars millions cash cash equivalents working capital debt net cash cash equivalents debt capital ratio net debt net capital employed return stockholders equity ratio computed total debt divided total debt stockholders equity ratio computed total debt net cash cash equivalents net debt divided bynet debt stockholders equity net capital employed ratio computed net income loss divided five quarter average stockholdersequity working capital primarily includes cash receivables inventories net drafts andaccounts payable liabilities our pharmaceutical solutions segment requires asubstantial investment working capital susceptible large variations yearas result inventory purchase patterns seasonal demands inventory purchase activity afunction sales activity new customer build requirements number timingof fee based arrangements pharmaceutical manufacturers in working capitaldecreased primarily result increases liabilities deferred revenue netfinancial inventory inventory net drafts accounts payable resulted small increase toworking capital working capital also decreased primarily due decrease ournet financial inventory partially offset improvements cash cash equivalent andrestricted cash balances increase accounts receivable improvements netfinancial inventory primarily reflect better alignment purchases customer demand forour us pharmaceutical distribution business our ratio net debt net capital employed decreased primarily due issuanceof billion long term debt relation per se acquisition our ratio net debtto net capital employed declined growth operating profit excess thegrowth working capital investments needed fund increases revenue the company paid quarterly cash dividends rate per share commonstock since fourth quarter dividend per share declared board onjanuary paid april stockholders record close businesson march the company anticipates continue pay quarterly cash dividends inthe future however payment amount future dividends remain within discretion ofthe board depend upon companys future earnings financial condition capitalrequirements factors table contents mckesson corporation financial review continued financial obligations commitments the table presents significant financial obligations commitments march years in millions total within over over after on balance sheet securities litigation long term debt other off balance sheet purchase obligations interest borrowings customer guarantees operatinglease obligations total primarily includes estimated payments pension postretirement plans we define purchase obligation arrangement purchase goods services isenforceable legally binding company these obligations primarily relate inventorypurchases capital commitments service agreements we agreements certain customers financial institutions primarily ourcanadian business guaranteed repurchase inventory discount theevent customers unable meet certain obligations financial institutionsamong limitations inventories must resalable condition we also guaranteedloans credit facilities customers secured lender substantially ofthese guarantees customer guarantees range one seven years primarily provided tofacilitate financing certain strategic customers at march maximum amounts ofinventory repurchase guarantees customer guarantees million million weconsider unlikely would make significant payments guarantees andaccordingly amounts accrued guarantees nominal in addition banks insurance companies issued million standby letters ofcredit surety bonds behalf order meet security requirements statutorylicenses permits court fiduciary obligations workers compensation automotiveliability programs credit resources we fund working capital requirements primarily cash short term borrowings ourreceivables sale facility we billion five year senior unsecured revolving creditfacility expires september borrowings credit facility bear interest basedupon either prime rate london interbank offering rate libor in june renewedour committed accounts receivable sales facility the facility renewed substantiallysimilar terms previously place exception facility reduced million billion the renewed facility expires june at march march amounts outstanding facilities in connection purchase per se january entered single draw billion interim credit facility the interim credit facility day unsecured facilitywhich terms substantially similar contained companys existing revolving creditfacility on january borrowed billion interim credit facility topartially fund per se acquisition on march issued million notes due million notes due the notes redeemable time whole orin part option in addition upon occurrence change control ratingsdowngrade notes non investment grade levels required make offer redeemthe notes price equal principal amount plus accrued interest we utilized netproceeds offering expenses table contents mckesson corporation financial review continued issuance notes million together cash hand repay billionshort term credit facility borrowings our senior debt credit ratings sp fitch moodys currently bbb bbb baaand commercial paper ratings currently our ratings outlook positivewith sp stable fitch moodys our various borrowing facilities certain long termdebt instruments subject covenants our principal debt covenant debt capitalratio cannot exceed if exceed ratio repayment debt outstanding therevolving credit facility million term debt could accelerated at march ratio compliance covenants reduction creditratings lack compliance covenants could result negative impact ourability finance operations funds necessary resolution future debt maturities cash requirementsare expected met existing cash balances cash flows operations existing creditsources capital market transactions market risks interest rate risk our long term debt bears interest predominately fixed rates whereasour short term borrowings variable interest rates if underlying weighted averageinterest rate variable rate debt changed bp interestexpense would materially different reported as march net fair value liability financial instruments withexposure interest rate risk approximately million million fair value wasestimated basis quoted market prices although trading debt securities islimited may reflect fair value fair value subject fluctuations based ourperformance credit ratings changes value stock changes interest ratesfor debt securities similar terms foreign exchange risk we derive revenues earnings canada united kingdomireland france netherlands israel australia new zealand mexico expose us tochanges foreign exchange rates we seek manage foreign exchange risk part throughoperational means including managing currency revenues relation currency costsand currency assets relation currency liabilities foreign exchange risk alsomanaged use foreign currency forward exchange contracts these contracts usedto offset potential earnings effects mostly intercompany foreign currency investments andloans as march adverse change quoted foreign currency exchangerates would material impact net fair value financial instruments haveexposure foreign currency risk related party balances and transactions information regarding related party balances transactions included criticalaccounting policies estimates appearing within financial review financial note related party balances transactions accompanying consolidated financial statements new accounting pronouncements new accounting pronouncements impact company included financial note significant accounting policies consolidated financial statements captionsshare based payment new accounting pronouncements factors affecting forward looking statements in addition historical information managements discussion analysis includes certainforward looking statements within meaning section securities act asamended section securities exchange act amended some theforward looking statements identified use forward looking words believesexpects anticipates may seeks approximately table contents mckesson corporation financial review continued intends plans orestimates negative words comparable terminology the discussionof financial trends strategy plans intentions may also include forward lookingstatements forward looking statements involve risks uncertainties could cause actualresults differ materially projected anticipated implied although notpossible predict identify risks uncertainties may include notlimited factors discussed additional factors that may affect future results thereader consider list complete statement potential risks anduncertainties these risks uncertainties described herein public documentsreaders cautioned place undue reliance forward looking statements speakonly date hereof we undertake obligation publicly release result anyrevisions forward looking statements reflect events circumstances datehereof reflect occurrence unanticipated events additional factors that may affect future results the following additional factors may affect future results adverse resolution pending securities litigation regarding restatement historicalfinancial statements may cause us incur material losses as discussed financial note other commitments contingent liabilities theaccompanying consolidated financial statements third quarter announced wehad reached agreement settle action captioned in mckesson hboc inc securitieslitigation noc rmw consolidated action in general agreed pay thesettlement class total million cash during third quarter recorded amillion pre tax million tax charge respect companys securitieslitigation the charge consisted million consolidated action million forother securities litigation proceedings on february court gave final approval settlement consolidatedaction result paid approximately million escrow account established bythe lead plaintiff connection settlement based payments made theconsolidated action payments made settle previously reported securities litigationproceedings based assessment remaining cases estimated securitieslitigation accruals march million million we believethis accrual adequate address remaining potential exposure respect thesecurities litigation matters however view number uncertainties timing andoutcome type litigation substantial amounts involved possible theultimate costs matters could impact earnings either negatively positively thequarter resolution we believe resolution matters amaterial adverse effect results operations liquidity financial position taken awhole changes united states healthcare environment could material negative impact ourrevenues net income our products services primarily intended function within structure thehealthcare financing reimbursement system currently used united states in recentyears healthcare industry changed significantly effort reduce costs thesechanges include increased use managed care cuts medicare medicaid reimbursement levelsconsolidation pharmaceutical medical surgical supply distributors development oflarge sophisticated purchasing groups we expect healthcare industry continue change significantly future some ofthese changes adverse changes government funding healthcare services legislation orregulations governing privacy patient information delivery pricing ofpharmaceuticals healthcare services mandated benefits may cause healthcare industryparticipants greatly reduce amount products services purchase pricethey willing pay products services changes healthcare industrys individual collective group ofpharmaceutical suppliers pricing selling inventory distribution supply policies orpractices changes customer mix could also significantly reduce revenues netincome due diverse range healthcare supply management table contents mckesson corporation financial review continued healthcare informationtechnology products services offer changes could adverse impacton results operations affecting competitors offer narrowerrange products services the majority us pharmaceutical distribution business agreements manufacturersare structured ensure appropriately predictably compensated services weprovide however failure successfully renew contracts timely favorable mannercould adverse impact results operations healthcare public policy trends indicate number generic drugs increaseover next years result expiration certain drug patents in recent yearsour revenues gross margins increased generic drug offering programs an increaseor decrease availability changes pricing reimbursement generic drugscould adverse impact results operations there increasing efforts various levels government including state boards ofpharmacy comparable agencies regulate pharmaceutical distribution system order toprevent introduction counterfeit adulterated andor mislabeled drugs thepharmaceutical distribution system pedigree tracking certain states adopted areconsidering laws regulations intended protect integrity pharmaceuticaldistribution system government agencies currently evaluating recommendationsflorida adopted pedigree tracking requirements california enacted law requiringchain custody technology using radio frequency tagging electronic pedigrees finalregulations federal prescription drug marketing act requiring pedigree chain ofcustody tracking certain circumstances became effective december this latterregulation challenged case brought secondary distributors preliminaryinjunction issued federal district court eastern district new york thattemporarily enjoined implementation regulation these pedigree tracking laws andregulations could increase overall regulatory burden costs associated ourpharmaceutical distribution business could adverse impact results ofoperations we subject extensive frequently changing local state federal laws andregulations relating healthcare fraud the federal government continues strengthen itsposition scrutiny practices involving healthcare fraud affecting medicare medicaid andother government healthcare programs furthermore relationships pharmaceutical andmedical surgical product manufacturers healthcare providers subject business laws andregulations fraud abuse many regulations applicable us including relatingto marketing incentives offered pharmaceutical medical surgical suppliers vague orindefinite interpreted courts they may interpreted applied aprosecutorial regulatory judicial authority manner could require us make changesin operations if fail comply applicable laws regulations could suffercivil criminal penalties including loss licenses ability participate inmedicare medicaid federal state healthcare programs medical billing collection activities governed numerous federal state civil andcriminal laws pertain companies provide billing collection services thatprovide consulting services connection billing collection activities in connectionwith laws may subjected federal state government investigations possiblepenalties may imposed upon us false claims actions may defended private payers mayfile claims us may excluded medicare medicaid government fundedhealthcare programs any proceeding investigation could adverse impact ourresults operations competitionmay erode profit in every area healthcare distribution operations pharmaceutical solutions andmedical surgical solutions segments face strong competition price service fromnational regional local full line short line specialty wholesalers servicemerchandisers self warehousing chains manufacturers engaged direct distribution largepayor organizations in addition segments face competition various serviceproviders pharmaceutical healthcare manufacturers well potentialcustomers segments may time time decide develop internalneeds supply management capabilities provided segments competingservice providers price quality service cases convenience customer aregenerally principal competitive elements segments table contents mckesson corporation financial review continued our provider technologies segmentexperiences substantial competition many firms including computer services firmsconsulting firms shared service vendors certain hospitals hospital groups hardware vendorsandinternet based companies technology applicable healthcare industry competitionvaries size small large companies geographical coverage scope breadth ofproducts services offered these competitive pressures could adverse impact ourresults operations our pharmaceutical solutions segment subject inflation branded pharmaceutical prices anddeflation generic pharmaceutical prices subjects us risks uncertainties certain us pharmaceutical distribution business agreements entered brandedpharmaceutical manufacturers partially inflation based slowing frequency rate ofbranded price increases could adverse impact results operations in addition wealso distribute generic pharmaceuticals subject price deflation an acceleration ofthe frequency rate generic price decreases could also adverse impact resultsof operations substantial defaults payment material reduction purchases products largecustomers could significant negative impact financial condition results ofoperations liquidity in recent years significant portion revenue growth limited number oflarge customers during year ended march sales ten largest customersaccounted approximately total consolidated revenues sales largest customercaremark rx inc represented approximately total consolidated revenues at march accounts receivable ten largest customers caremark rx inc wereapproximately total accounts receivable as result sales creditconcentration significant any defaults payment material reduction purchases fromthis large customer could adverse impact results operations our pharmaceutical solutions medical surgical solutions segments dependent uponsophisticated information systems the implementation delay malfunction failure thesesystems extended period time could adversely affect business we rely sophisticated information systems business obtain rapidly processanalyze manage data facilitate purchase distribution thousands inventoryitems numerous distribution centers receive process ship orders timely basismanage accurate billing collections thousands customers process payments tosuppliers if systems interrupted damaged unforeseen events fail anyextended period time could adverse impact results operations we could become subject liability claims adequately covered insurance andmay pay damages expenses could adverse impact results ofoperations our business exposes us risks inherent distribution manufacturingdispensing pharmaceuticals medical surgical supplies provision ancillary servicesthe conduct payor businesses include disease management programs nurse triageservices provision products assist clinical decision making relate patientmedical histories treatment plans if customers assert liability claims productsandor services ensuing litigation regardless outcome could result substantial costto us divert managements attention operations decrease market acceptance ourproducts we attempt limit contract liability customers however limitationsof liability set forth contracts may enforceable may otherwise protect us fromliability damages we also maintain general liability coverage however coverage may notcontinue available acceptable terms may available sufficient amounts coverone large claims us in addition insurer might disclaim coverage anyfuture claim successful product professional liability claim fully covered ourinsurance could adverse impact results operations table contents mckesson corporation financial review continued the failure provider technologies business attract retain customers due challengesin software product integration keep pace technological advances may significantlyreduce revenues increase expenses our provider technologies business delivers enterprise wide patient care clinical financialsupply chain strategic management software solutions pharmacy automation hospitalsphysicians homecare providers retail mail order pharmacies payors challenges inintegrating provider technologies software products could impair ability attract retaincustomers could adverse impact results operations future advances healthcare information systems industry could lead new technologiesproducts services competitive products services offered providertechnologies business such technological advances could also lower cost products andservices otherwise result competitive pricing pressure the success providertechnologies business depend part ability responsive technologicaldevelopments pricing pressures changing business models to remain competitive theevolving healthcare information systems marketplace provider technologies business mustdevelop new products timely basis the failure develop competitive products tointroduce new products timely basis could curtail ability provider technologiesbusiness attract retain customers thereby could adverse impact results ofoperations the loss third party licenses utilized provider technologies segment may adversely impactour operating results we license rights use certain technologies third party vendors incorporate inor complement provider technologies segments products solutions these licenses aregenerally nonexclusive must renewed periodically mutual consent may terminated webreach terms license as result may discontinue delay reduce productshipments obtain equivalent technology could hurt business our competitorsmay obtain right use technology covered licenses use technologyto compete directly us in addition vendors choose discontinue support thelicensed technology future may able modify adapt products proprietary technology protections may adequate products may found infringe therights third parties we rely combination trade secret patent copyright trademark laws nondisclosureand contractual provisions technical measures protect proprietary rights ourproducts there assurance protections adequate ourcompetitors independently develop technologies substantially equivalent orsuperior technology although believe products infringe proprietaryrights third parties time time third parties asserted infringement claims againstus assurance third parties assert infringement claims usin future if found infringing others rights may required paysubstantial damage awards forced develop non infringing technology obtain license orcease selling products contain infringing technology additionally may find itnecessary initiate litigation protect trade secrets enforce patent copyright andtrademark rights determine scope validity proprietary rights othersthese types litigation costly time consuming these litigation expenses damagepayments costs developing replacement technology could adverse impact resultsof operations system errors failures products conform specifications could cause unforeseenliabilities the software software systems systems sell operate complex aswith complex systems offered others systems may contain errors especially firstintroduced for example provider technologies business systems intended provideinformation healthcare providers providing patient care therefore users systemshave greater sensitivity errors general market software products failure aclients system perform accordance documentation could constitute breach ofwarranty could require us incur additional expense order make system comply withthe documentation if failure remedied timely manner could constitute amaterial breach table contents mckesson corporation financial review continued contract allowing client cancel contract obtain refunds ofamounts previously paid assert claims significant damages regulation distribution businesses regulation computer related products couldimpose increased costs delay introduction new products negatively impact business the healthcare industry highly regulated we subject various local state federalforeign transnational laws regulations include operating security standardsof drug enforcement administration dea food drug administration fdavarious state boards pharmacy state health departments department health humanservices dhhs comparable agencies certain subsidiaries may requiredto register permits andor licenses comply operating security standards ofthe dea fda dhhs various state boards pharmacy state health departments andorcomparable state agencies well foreign agencies certain accrediting bodies depending uponthe type operations location product distribution manufacturing sale inaddition fda increasingly focused regulation computer products andcomputer assisted products medical devices federal food drug cosmetic act ifthe fda chooses regulate products medical devices impose extensiverequirements upon us if fail comply applicable requirements fda could respondby imposing fines injunctions civil penalties requiring recalls product correctionssuspending production refusing grant pre market clearance products withdrawing clearancesand initiating criminal prosecution any final fda policy governing computer products onceissued may increase cost time market new existing products may prevent us frommarketing products weregularly receive requests information occasionallysubpoenas governmental authorities although believe compliance material respects applicable lawsand regulations assurance regulatory agency tribunal would reach adifferent conclusion concerning compliance operations applicable laws andregulations in addition assurance able maintain renewexisting permits licenses regulatory approvals obtain without significant delayfuture permits licenses approvals needed operation businesses anynoncompliance us applicable laws regulations failure maintain renew orobtain necessary permits licenses could adverse impact results operations new potential federal regulations relating patient confidentiality format datacontent standards could depress demand products impose significant product redesigncosts unforeseen liabilities us state federal laws regulate confidentiality patient records circumstancesunder records may released these regulations govern disclosure use ofconfidential patient medical record information require users information toimplement specified security measures regulations currently place governing electronic healthdata transmissions continue evolve often unclear difficult apply the health insurance portability accountability act hipaa requires nationalstandards types electronic health information transactions data elements usedin transactions security standards ensure integrity confidentiality healthinformation standards protect privacy individuallyidentifiable health information although systems updated modified comply current requirements ofhipaa evolving hipaa related laws regulations claims attachment rule couldrestrict ability customers obtain use disseminate patient information thiscould adversely affect demand products designed timely manner inorder meet requirements new regulations seek protect privacy securityof patient data enable customers execute new modified healthcare transactions we mayneed expend additional capital research development resources modify ourproducts address evolving data security privacy issues table contents mckesson corporation financial review continued the length sales implementation cycles provider technologies segment could havean adverse impact future operating results many solutions offered provider technologies segment long sales andimplementation cycles could range several months two years initialcontact customer completion implementation how implement replace orexpand information system modify add business processes major decisions forhealthcare organizations many solutions provide typically require significant capitalexpenditures time commitments customer any decision customers delayimplementation could adverse impact results operations furthermore delays orfailures meet milestones established agreements may result breach contracttermination agreement damages andor penalties well reduction margins adelay ability recognize revenue our inability perform well chronic disease impact condition programs could anadverse effect business results operations part growth strategy focuses developing health care support programs addresschronic diseases medical conditions well overall health enrollees healthplan our success area including ability recognize revenue highly dependentupon timely receipt accurate data health plan customers accurate analysis ofsuch data data acquisition data quality control data analysis complex processes thatcarry risk untimely incomplete inaccurate data health plan customers flawedanalysis data if receive timely accurate data health plan customers orour analyses flawed fail execute new modified programs could anadverse impact results operations reduced capacity commercial property insurance market exposes us potential loss in order provide prompt complete service major pharmaceutical solutions andmedical surgical solutions customers maintain significant product inventory certain ourdistribution centers while seek maintain property insurance coverage amounts sufficientfor business assurance property insurance adequate oravailable acceptable terms one large casualty losses caused fire earthquake orother natural disaster excess coverage limits could adverse impact resultsof operations we may required record significant charge earnings goodwill amortizableintangible assets become impaired we required generally accepted accounting principles test goodwill forimpairment least annually well review amortizable intangible assets impairmentwhen events changes circumstances indicate carrying value may recoverablefactors may considered change circumstances indicating carrying value ourintangible assets may recoverable include slower growth rates loss significantcustomer we may required record significant charge earnings consolidatedfinancial statements period impairment goodwill amortizableintangible assets determined this could adverse impact results operations table contents mckesson corporation financial review continued our operating results financial condition may adversely affected foreign operations we operations based foreign countries including canada united kingdom europeand foreign countries large investment mexico in future look tocontinue grow foreign operations organically acquisitions investmentshowever increasing foreign operations carries additional risks operations outside theunited states may affected changes trade protection laws policies measures otherregulatory requirements affecting trade investment unexpected changes regulatoryrequirements software social political labor economic conditions specific country orregion importexport regulations united states foreign countries difficultiesin staffing managing foreign operations political changes natural disasters ofwhich may disruptive interfere supply chain customers ouractivities particular location additionally foreign operations expose us foreigncurrency fluctuations could adversely impact results operations based movementsof applicable foreign currency exchange rates relation us dollar tax legislation initiatives could adversely affect net earnings we large multinational corporation operations united states andinternational jurisdictions as subject tax laws regulations unitedstates federal state local governments many international jurisdictions from time totime various legislative initiatives may proposed could adversely affect taxpositions there assurance effective tax rate adversely affected bythese initiatives in addition united states federal state local well internationaltax laws regulations extremely complex subject varying interpretations although webelieve historical tax positions sound consistent applicable lawsregulations existing precedent assurance tax positions bechallenged relevant tax authorities would successful challenge our business could hindered unable complete integrate acquisitionssuccessfully an element strategy identify pursue consummate acquisitions eitherexpand complement business integration acquisitions involves number risksincluding diversion managements attention assimilation operations ofbusinesses acquired difficulties integration operations systems therealization potential operating synergies assimilation retention personnel ofthe acquired companies challenges retaining customers combined businesses andpotential adverse effects operating results in addition may potentially require additionalfinancing order fund future acquisitions may may attainable if areunable successfully complete integrate strategic acquisitions timely manner ourbusiness growth strategies could negatively affected in addition changes generally accepted accounting principles generaleconomic market conditions could affect future results table contents mckesson corporation financial review continued managements annual report on internal control over financial reporting the management mckesson corporation responsible establishing maintainingadequate internal control financial reporting company with participation thechief executive officer chief financial officer management conducted evaluation ofthe effectiveness internal control financial reporting based framework andcriteria established internal controlintegrated framework issued committee ofsponsoring organizations treadway commission based evaluation management hasconcluded internal control financial reporting effective march deloitte touche llp independent registered public accounting firm issued auditreport managements assessment internal control financial reporting this auditreport appears page annual report form the scope managements assessment effectiveness internal control financialreporting excludes acquired operations per se technologies inc per se wasacquired january per se representsapproximately total assetsat march less revenues andnet income year ended march may john hammergren john hammergren chairman president chief executive officer principal executive officer jeffrey campbell jeffrey campbell executive vice president chief financial officer principal financial officer table contents mckesson corporation report of independent registered public accounting firm the stockholders board directors mckesson corporation we audited accompanying consolidated balance sheets mckesson corporation andsubsidiaries company march related consolidated statementsof operations stockholders equity cash flows three fiscal years periodended march our audits also included financial statement schedule listed theindex itema we also audited managements assessment included accompanying managements annual report internal control over financial reporting companymaintained effective internal control financial reporting march based oncriteria established internal controlintegrated framework issued committee sponsoringorganizations treadway commission as described managements annual report internalcontrol over financial reporting management excluded assessment internal control overfinancial reporting per se technologies inc per sewhich acquired january whose financialstatements constitute approximately totalassets less revenues net income year ended march accordingly audit include theinternal control financial reporting per se the companys management responsible forthese financial statements financial statement schedule maintaining effective internalcontrol financial reporting assessment effectiveness internal controlover financial reporting our responsibility express opinion financialstatements financial statement schedule opinion managements assessment opinionon effectiveness companys internal control financial reporting based ouraudits we conducted audits accordance standards public company accountingoversight board united states those standards require plan perform audit toobtain reasonable assurance whether financial statements free materialmisstatement whether effective internal control financial reporting maintained allmaterial respects our audit financial statements included examining test basis evidencesupporting amounts disclosures financial statements assessing accountingprinciples used significant estimates made management evaluating overall financialstatement presentation our audit internal control financial reporting included obtainingan understanding internal control financial reporting evaluating managements assessmenttesting evaluating design operating effectiveness internal control performingsuch procedures considered necessary circumstances we believe auditsprovide reasonable basis opinions companys internal control financial reporting process designed thesupervision companys principal executive principal financial officers personsperforming similar functions effected companys board directors management andother personnel provide reasonable assurance regarding reliability financial reportingand preparation financial statements external purposes accordance generallyaccepted accounting principles companys internal control financial reporting includesthose policies procedures pertain maintenance records reasonabledetail accurately fairly reflect transactions dispositions assets thecompany provide reasonable assurance transactions recorded necessary permitpreparation financial statements accordance generally accepted accounting principles andthat receipts expenditures company made accordance authorizationsof management directors company provide reasonable assurance regardingprevention timely detection unauthorized acquisition use disposition companysassets could material effect financial statements because inherent limitations internal control financial reporting includingthe possibility collusion improper management override controls material misstatementsdue error fraud may prevented detected timely basis also projections anyevaluation effectiveness internal control financial reporting future periodsare subject risk controls may become inadequate changes conditionsor degree compliance policies procedures may deteriorate in opinion consolidated financial statements referred present fairly allmaterial respects financial position mckesson corporation subsidiaries march theresults operations cash flows three fiscal years period endedmarch conformity accounting principles generally accepted united states ofamerica also opinion financial statement schedule considered relation tothe basic consolidated financial statements taken whole presents fairly materialrespects information set forth therein also opinion managements assessment thecompany maintained effective internal control financial reporting march isfairly stated material respects based criteria established internalcontrolintegrated framework issued committee sponsoring organizations treadwaycommission furthermore opinion company maintained material respectseffective internal control financial reporting march based criteriaestablished internal controlintegrated framework issued committee sponsoringorganizations treadway commission as discussed note consolidated financial statements april companychanged method accounting share based payment arrangements conform statementof financial accounting standards sfas norshare based payment as also discussed note theconsolidated financial statements march companyadopted sfas no employers accounting defined benefitpension other postretirement plans eloitte touche llp san francisco california may table contents mckesson corporation consolidated statements of operations in millions except per share amounts years ended march revenues cost sales gross profit operating expenses selling distribution research development administrative securities litigation charge credit net total operating income loss interest expense other income net income loss continuing operations before incometaxes income tax benefit provision income loss after income taxes continuing operations discontinued operations discontinued operations gain losson sales net net income loss earnings loss per common share diluted continuing operations discontinued operations discontinued operations gain losson sales net total basic continuing operations discontinued operations discontinued operations gain losson sales net total weighted average shares diluted basic see financial notes table contents mckesson corporation consolidated balance sheets in millions except per share amounts march assets current assets cash cash equivalents restricted cash receivables net inventories prepaid expenses total property plant equipment net capitalized software held sale goodwill intangible assets net other assets total assets liabilities and stockholders equity current liabilities drafts accounts payable deferred revenue current portion long term debt securities litigation other total postretirement obligations other noncurrentliabilities long term debt other commitments contingent liabilities note stockholders equity preferred stock par value sharesauthorized shares issued outstanding common stock par valueshares authorized shares issued additional paid capital other capital retained earnings accumulated other comprehensive income esop notes guarantees treasury shares cost total stockholders equity total liabilities stockholders equity see financial notes table contents mckesson corporation consolidated statements of stockholders equity years ended march in millions except per share amounts accumulated common additional other esop notes treasury stock paid other retained comprehensive common stockholders comprehensive shares amount capital capital earnings income loss guarantees shares amount equity income loss balances march issuance shares underemployee plans esop note collections note collections note reserves translation adjustment additional minimumpension liability net taxof net loss other cash dividends declared per common share balances march issuance shares underemployee plans esop note collections note collections note reserves translation adjustment additional minimumpension liability net taxof net income unrealized gain investmentsnet tax conversion debentures repurchase common stock cash dividends declared per common share balances march issuance shares underemployee plans share based compensation tax benefit related issuanceof shares employeeplans esop note collections notes rescinded note reserves translation adjustment additional minimumpension liability net taxof net income unrealized loss investmentsnet tax repurchase common stock cash dividends declared per common share adoption new accountingstandard net tax other balances march see financial notes table contents mckesson corporation consolidated statements of cash flows in millions years ended march operating activities net income loss discontinued operations net income taxes adjustments reconcile net cash provided used inoperating activities depreciation amortization provision bad debts securities litigation charge credit net deferred taxes other non cash items changes operating assets liabilities net acquisitions receivables inventories drafts accounts payable deferred revenue taxes securities litigation settlement payments proceeds sale notes receivable other net cash provided operating activities investing activities property acquisitions capitalized software expenditures acquisitions businesses less cash cash equivalentsacquired proceeds sale businesses restricted cash other net cash used investing activities financing activities proceeds issuances debt net repayment debt capital stock transactions issuances share repurchases esop notes guarantees dividends paid other net cash provided used financing activities netincreasedecrease cash cash equivalents cash cash equivalents beginning year cash cash equivalents end year supplemental information cash paid interest income taxes non cash transaction common stock issued conjunction redemption oflong term debt see financial notes table contents mckesson corporation financial notes significant accounting policies nature operations the consolidated financial statements mckesson corporationmckesson company similar pronouns include financial statements ofall majority owned controlled companies significant intercompany transactions balanceshave eliminated the companys fiscal year begins april ends march unlessotherwise noted references particular year shall mean companys fiscal year we conduct business three segments through pharmaceutical solutions segmentwe leading distributor ethical proprietary drugs health beauty care productsthroughout north america this segment also provides medical management specialtypharmaceutical solutions biotech pharmaceutical manufacturers patient servicesfor payors software consulting outsourcing services pharmacies itsinvestment parata systems llc parata sells automated pharmaceutical dispensing systems forretail pharmacies our medical surgical solutions segment distributes medical surgical suppliesfirst aid products equipment provides logistics services within unitedstates canada our provider technologies segment delivers enterprise wide patient careclinical financial supply chain strategic management software solutions pharmacy automationfor hospitals well connectivity outsourcing services healthcare organizationsthroughout north america united kingdom european countries its customers includehospitals physicians homecare providers retail pharmacies payors reclassifications certain prior year amounts reclassified conform thecurrent year presentation the reclassifications primarily related discontinued operationssee financial note discontinued operations impact net income use estimates the preparation financial statements conformity accountingprinciples generally accepted united states america requires make estimates andassumptions affect reported amounts assets liabilities disclosure contingentassets liabilities date financial statements reported amounts ofrevenues expenses reporting period actual results could differ thoseestimates cash cash equivalents all highly liquid debt instruments purchased maturity ofthree months less date acquisition included cash cash equivalents restricted cash cash subject legal restrictions unavailable generaloperating purposes classified restricted cash at march restricted cashincluded million paid escrow account future distribution class members oursecurities litigation settlement the corresponding liability current liabilities thecaption securities litigation the liability discharged time settlementis declared effective court refer financial note other commitments contingentliabilities marketable securities available sale we carry marketable securities areavailable sale fair value net unrealized gains losses net related taxeffect computed marking securities market reported within stockholdersequity inventories we state inventories lower cost market inventories thepharmaceutical solutions medical surgical solutions segments consist merchandise held forresale for pharmaceutical solutions segment majority cost domestic inventoriesis determined last first lifo method canadian inventories stated usingthe first first fifo method cost inventories medical surgical solutionssegment primarily determined fifo method provider technologies segment inventoriesconsist computer hardware cost determined standard cost method the lifo method isused value approximately inventories march total inventoriesbefore lifo cost adjustment approximates replacement cost million andmillion march vendor rebates cash discounts allowances andchargebacks received vendors generally accounted reduction cost ofinventory recognized inventory sold table contents mckesson corporation financial notes continued property plant equipment we state property plant equipment cost anddepreciate straight line method rates designed distribute cost propertiesover estimated service lives ranging one years capitalized software held sale development costs software held sale whichprimarily pertain provider technologies segment capitalized project reachedthe point technological feasibility completed projects amortized reaching pointof general availability using straight line method based estimated useful life ofapproximately three years we monitor net realizable value capitalized software held forsale ensure investment recovered future sales additional information regarding capitalized software expenditures follows years ended march in millions amounts capitalized amortization expense third party royalty fees paid long lived assets we assess recoverability goodwill indefinite lived purchasedintangible assets least annual basis long lived assets events changes incircumstances indicate carrying amount asset may recoverable measurement ofimpairment losses long lived assets including goodwill expect hold use isbased estimated fair values assets estimates fair values based quoted marketprices available results valuation techniques utilizing discounted cash flows usingthe lowest level identifiable cash flows fundamental analysis long lived assets bedisposed either sale abandonment reported lower carrying amount fairvalue less costs sell intangible assets finite livescustomer lists technology trademarks amortized astraight line basis estimated useful lives ranging oneto twenty years capitalized software held internal use we amortize capitalized software held forinternal use assets estimated useful lives ranging one ten years as march capitalized software held internal use million millionnet accumulated amortization million andmillion included other assetsin consolidated balance sheets insurance programs under insurance programs seek obtain coverage catastrophicexposures well risks required insured law contract it policy toretain significant portion certain losses primarily related workers compensation andcomprehensive general product vehicle liability provisions losses expected theseprograms recorded based upon estimate aggregate liability claims incurred aswell claims incurred yet reported such estimates utilize certain actuarialassumptions followed insurance industry revenue recognition revenues pharmaceutical solutions medical surgical solutionssegments recognized deliver product title passes customer serviceshave rendered obligations customers revenues recorded net sales returns allowances rebates we accrue sales returnsbased estimates time sale customer sales returns customers wereapproximately million million million taxescollected customers remitted governmental authorities presented net basisthat excluded revenues the revenues pharmaceutical solutions segment include large volume sales ofpharmaceuticals limited number large customers warehouse product we orderbulk product manufacturer receive process product centraldistribution facility deliver bulk product generally form received themanufacturer directly customers warehouses we also record revenues direct storedeliveries customers sales customer warehouses amounted billion billion billion direct store deliveries areshipments manufacturer customers limited category products requirespecial handling we assume primary liability manufacturer products table contents mckesson corporation financial notes continued based criteria emerging issues task force eitf issue no reportingrevenue gross principal versus net agent revenues recorded gross arethe primary party obligated thetransaction take title possession inventory subject inventory riskhave latitude establishing prices assume risk loss collection customers wellas delivery return product responsible fulfillment customer servicerequirements transactions several indicators our pharmaceutical solutions segment also includes revenues disease management programsprovided various states medicaid programs these service contracts include provisions forachieving certain cost savings clinical targets if targets met portion orall revenue must refunded customer we recognize revenue term thecontract assessing actual performance compared targets determining amountthe customer would legally obligated pay contract terminated point theseassessments include estimates medical claims data could require futureadjustment generally significant time delay recording accrual andthe final settlement contract if data insufficient assess performance notmet targets defer recognition revenue as march haddeferred million million related contracts included incurrent deferred revenue consolidated balance sheets we generally successful inachieving performance goals contracts revenues provider technologies segment generated primarily licensing softwaresystems consisting software hardware maintenance support providing outsourcing andprofessional services revenue segment recognized follows software systems marketed information systems agreements well serviceagreements perpetual software arrangements recognized time delivery thepercentage completion method based terms conditions contract contractsaccounted percentage completion method generally measured based ratioof labor costs incurred date total estimated labor costs incurred changes inestimates complete revisions overall profit estimates contracts charged toearnings period determined we accrue contract losses thecurrent estimate total contract costs exceeds total contract revenue hardware revenues generally recognized upon delivery revenue multi year softwarelicense agreements recognized ratably term agreement software implementationfees recognized work performed percentage completion contract methodmaintenance support agreements marketed annual multi year agreements arerecognized ratably period covered agreements remote processing service fees arerecognized monthly service performed outsourcing service revenues recognized theservice performed we also offer products application service provider asp basis making availableour software functionality remote hosting basis data centers the data centersprovide system administrative support well hosting services revenue products sold onan asp basis recognized monthly basis term contract starting thehosting services begin this segment also engages multiple element arrangements may contain combinationof software hardware implementation consulting services maintenance services when someelements delivered prior others arrangement vendor specific objective evidence offair value vsoe exists undelivered elements revenue delivered elements isrecognized upon delivery items the segment establishes vsoe hardware andimplementation consulting services based price charged sold separately formaintenance services based renewal rates offered customers revenue softwareelement recognized residual method fair value established allof undelivered elements arrangement if fair value cannot established anyundelivered element arrangements revenue deferred delivery lastelement fair value undelivered element determinable supplier incentives we generally account fees service incentives receivedfrom suppliers relating purchase distribution inventory reduction costof goods sold we consider fees represent product discounts result feesare recorded reduction product cost recognized cost goods sold upon saleof related inventory table contents mckesson corporation financial notes continued supplier reserves we establish reserves amounts due suppliers relating tovarious price rebate incentives including deductions billings taken paymentsotherwise due these reserve estimates established based judgment aftercarefully considering status current outstanding claims historical experience thesuppliers specific incentive programs pertinent informationavailable us we evaluate amounts due suppliers continual basis andadjust reserve estimates appropriate based changes factual circumstances theultimate outcome outstanding claim may different estimate as march supplier reserves million million shipping handling costs we include costs warehouse pick pack deliverinventory customers distribution expenses income taxes we account income taxes asset liability method whichrequires recognition deferred tax assets liabilities expected future taxconsequences events included financial statements under methoddeferred tax assets liabilities determined based difference financialstatements tax basis assets liabilities using enacted tax rates effect yearin differences expected reverse foreign currency translation assets liabilities international subsidiaries aretranslated us dollars year end exchange rates revenues expenses translatedat average exchange rates year cumulative currency translation adjustments areincluded accumulated comprehensive income losses stockholders equity section theconsolidated balance sheets realized gains losses currency exchange transactions arerecorded operating expenses consolidated statements operations materialto consolidated results operations derivative financial instruments derivative financial instruments used principally inthe management foreign currency interest rate exposures recorded balancesheet fair value if derivative designated fair value hedge changes thefair value derivative hedged item attributable hedged risk recognizedas charge credit earnings if derivative designated cash flow hedge theeffective portions changes fair value derivative recorded accumulated othercomprehensive losses recognized consolidated statement earnings hedgeditem affects earnings ineffective portions changes fair value cash flow hedges arerecognized charge credit earnings derivative instruments designated hedges aremarked market end accounting period results included earnings concentrations credit risk trade receivables subject us concentration credit riskwith customers primarily pharmaceutical solutions segment significant proportion ourrevenue growth limited number large customers result creditconcentration increased accordingly defaults payment reduction purchasesfrom large customers could significant negative impact financial conditionresults operations liquidity at march revenues accounts receivable ourten largest customers accounted approximately consolidated revenues approximately accounts receivable revenues march receivables largestcustomer caremark rx inc represented approximately total consolidated revenues accounts receivable we also provided financing arrangements certain customerswithin pharmaceutical solutions segment revolving basis at march customer financing arrangements totaled approximately million accounts receivable sales at march million revolving receivablessales facility fully available the program qualifies sale treatment understatement financial accounting standards sfas no accounting for transfers andservicing financial assets extinguishments liabilities sales recorded theestimated fair values receivables sold reflecting discounts time value moneybased us commercial paper rates estimated loss provisions discounts recorded inadministrative expenses consolidated statements operations share based payment beginning account share based payment transactionsusing fair value based measurement method required sfas nor share based paymentthe share based compensation expense recognized portion awards ultimatelyexpected vest straight table contents mckesson corporation financial notes continued line basis requisite service period awards withgraded vesting service conditions for awards performance conditions recognizethe expense straight line basis treating vesting tranche separate award prior adoption sfas nor accounted employee stock basedcompensation plans using intrinsic value method accounting principles board apbopinion no accounting stock issued employees under policy since exerciseprice stock options granted generallyset equal market price date grant record expense theincome statement related grants stock options unless certain original grant date termswere subsequently modified see financial note share based payment pro forma effecton net income lossand diluted earnings lossper common share required disclosureprovisions sfas no accounting stock based compensation amended sfas noaccounting stock based compensation transition disclosure years ended march new accounting pronouncements in november financial accounting standards boardfasb issued sfas no inventory costs amendment accounting research bulletinarb no chapter sfas no clarifies accounting guidance included arb nochapter inventory pricing related abnormal amounts idle facility expense freighthandling spoilage costs sfas no became effective inventory costs incurred the adoption standard material effect consolidated financialstatements on april adopted sfas nor share based payment requires therecognition expense resulting transactions acquire goods services byissuing shares share options equity instruments this standard requires afair value based measurement method accounting share based payment transactions theshare based compensation expense recognized portion awards ultimatelyexpected vest this standard replaced sfas no superseded apb opinion noaccordingly use intrinsic value method provided apb opinion no wasutilized company eliminated we adopted sfas nor using modified prospectivemethod transition see financial note share based payment details in march securities exchange commission sec staff issued staff accountingbulletin sab no share based payment provides guidance interaction betweensfas nor certain sec rules regulations well valuation share basedpayments sab no modify requirements sfas nor sab noprovides interpretive guidance related valuation methods including assumptions expectedvolatility expected term first time adoption sfas nor interim period theclassification compensation expense disclosures subsequent adoption sfas nor operating income included million million share based compensationexpense expense associated restricted stock whose intrinsic value grantdate amortized remaining requisite service period we anticipate impact ofsfas nor continue impact net income future awards share based compensation aregranted amortized requisite service period four years share based compensationcharges affected stock price well assumptions regarding number complex andsubjective variables related tax impact these variables include limited tothe volatility stock price employee stock option exercise behaviors timing level andtypes grants annual share based awards attainment performance goals as aresult actual future share based compensation expense may differ historical levels ofexpense in december fasb issued sfas no exchanges nonmonetary assets anamendment apb opinion no eliminates exception fair value measurement fornonmonetary exchanges similar productive assets culminate earning process underapb opinion no accounting nonmonetary transactions sfas no requires thatmeasurement based recorded amount assets relinquished nonmonetary exchangesthat commercial substance nonmonetary exchange commercial substance thefuture cash flows entity expected change significantly result exchangethis standard became effective nonmonetary asset exchanges the adoption thisstandard material impact consolidated financial statements table contents mckesson corporation financial notes continued in february fasb issued sfas no accounting certain hybrid financialinstruments amendment fasb statements no sfas no clarifies certainissues relating embedded derivatives beneficial interests securitized financial assetsincluding permitting fair value measurement hybrid financial instrument contains anembedded derivative eliminating prohibition qualifying special purpose entity fromholding certain derivative instruments providing clarification concentrations creditrisk form subordination embedded derivatives this standard effective usfor financial instruments acquired issued we believe adoption ofthis standard material impact consolidated financial statements in july fasb issued financial interpretation fin no accounting foruncertainty income taxes clarifies accounting uncertainty income taxesrecognized financial statements accordance sfas no accounting incometaxes fin no provides tax benefit uncertain tax position may recognizedwhen likely position sustained upon examination includingresolutions related appeals litigation processes based technical merits theamount recognized measured largest amount tax benefit greater percentlikely realized upon ultimate settlements this interpretation also provides guidance onmeasurement derecognition classification interest penalties accounting interim periodsdisclosure transition we required adopt provisions fin no firstquarter while assessing impact fin no consolidated financialstatements currently estimate cumulative effect upon adoption fin no may result adecrease shareholders equity million the estimated impact subject revisionas complete analysis we continue classify interest penalties paid anunderpayment income taxes income taxes consolidated statements operations in september fasb issued sfas no fair value measurements defines fairvalue establishes framework measuring fair value expands disclosures fair valuemeasurements this standard applies accounting pronouncements require permitfair value measurements require new fair value measurements sfas no willbecome effective us we currently assessing impact sfas no in september sec staff issued sab no considering effects prior yearmisstatements quantifying misstatements current year financial statements this guidanceindicates materiality misstatement must evaluated using rollover ironcurtain approaches the iron curtain approach quantifies misstatement based effects ofcorrecting misstatement existing balance sheet end current year therollover approach quantifies misstatement based amount error originating thecurrent year income statement sab no effective annual consolidated financialstatements the adoption sab no material effect consolidatedfinancial statements in september fasb issued sfas no employers accounting defined benefitpension other postretirement plans requires us recognize funded status ourdefined benefit plans consolidated balance sheets changes funded status incomprehensive income this standard also requires us recognize gainslosses prior yearservice costscredits transition assetsobligations component comprehensiveincome upon adoption provide additional annual disclosure sfas no affect thecomputation benefit expense recognized consolidated statements operations inaddition sfas no requires us measure plan assets benefit obligations theyear end balance sheet date effective we adopted recognition disclosureprovisions standard required prospectively table contents mckesson corporation financial notes continued the following table sets forth incremental effect applying sfas no individualline items consolidated balance sheet march before after adoption adoption in millions sfas no adjustments sfas no other assets current liabilities other postretirement obligations othernoncurrent liabilities accumulated other comprehensive income the adoption sfas no also impacted subtotals consolidated balance sheetincluding total assets total current liabilities total stockholders equity in february fasb issued sfas no the fair value option financialassets financial liabilities including amendment fasb statement no sfas nopermits us elect fair value initial subsequent measurement attribute certainfinancial assets liabilities otherwise required measured fair value onan instrument instrument basis if elect fair value option would required torecognize changes fair value earnings this standard also establishes presentation anddisclosure requirements designed improve comparisons entities choose differentmeasurement attributed similar types assets liabilities sfas no effective although early adoption permitted we currently assessing impact sfas noon consolidated financial statements acquisitions investments in made following acquisitions investment on january acquired outstanding shares ofper se technologies inc per se alpharetta georgia per share cash plus assumption per ses debt orapproximately billion aggregate including cash acquiredof million per se leading provider financial andadministrative healthcare solutions hospitals physicians andretail pharmacies the acquisition initially funded cashon hand use interim credit facility inmarch issued billion long term debt netproceeds offering expenses issuance together withcash hand used fully repay borrowingsoutstanding interim credit facility refer financialnote long term debt other financing the following table summarizes preliminary estimated fair values assets acquired andliabilities assumed acquisition march in millions accounts receivable property equipment other current non current assets goodwill intangible assets accounts payable other current liabilities deferred revenue long term liabilities net assets acquired less cash cash equivalents approximately million preliminary purchase price allocation assigned togoodwill included purchase price allocation acquired identifiable intangibles ofmillion representing customer relationships weighted average life yearsdeveloped technology million table contents mckesson corporation financial notes continued weighted average life years trademark andtradenames million weighted average life years in connection preliminary purchase price allocation estimated fair valueof support obligations assumed per se connection acquisition theestimated fair value obligations determined utilizing cost build approachthe cost build approach determines fair value estimating costs relating fulfillingthe obligations plus normal profit margin the sum costs operating profitapproximates theory amount would required pay third party assumethese obligations as result allocating purchase price recorded adjustment toreduce carrying value per ses deferred revenue million million whichrepresents estimate fair value obligation assumed in accordance accounting standards certain costs incurred integrateacquired businesses treated part cost acquisition whereas relatedcosts expensed financial results per se primarily included within providertechnologies segment since date acquisition our provider technologies segment acquired relayhealth corporationrelayhealth based emeryville california relayhealth aprovider secure online healthcare communication serviceslinking patients healthcare professionals payors pharmaciesthis segment also acquired two entities one specializingin patient billing solutions designed simplify enhancehealthcare providers financial interactions patientsas well provider integrated software electronic healthrecords medical billing appointment scheduling forindependent physician practices the total cost threeentities million paid cash goodwillrecognized transactions amounted million our medical surgical solutions segment acquired sterling medicalservices llc sterling based moorestown new jerseysterling national provider distributor disposablemedical supplies health management services qualitymanagement programs home care market this segment alsoacquired leading medical supply sourcing agent the total costof two entities million paid cashgoodwill recognized transactions amounted million we invested million cash million net assetsprimarily automated prescription systems business inparata systems llc parata exchange significantminority interest parata parata manufacturer pharmacyrobotic equipment in connection investment weabandoned certain assets resulted million charge tocost sales incurred million expenses relatedto transaction recorded within operating expenseswe recognize additional gains losses result ofthis transaction believe fair value investment inparata determined third party valuation approximates thecarrying value consideration contributed parata ourinvestment parata accounted equity method ofaccounting within pharmaceutical solutions segment in made following acquisitions we acquired issued outstanding stock dkhealthcare resources inc dk st louis missouri anaggregate cash purchase price million including theassumption dks debt dk primarily wholesaledistributor branded generic pharmaceuticals andover counter health beauty products independent andregional pharmacies primarily midwest approximately million purchase price assigned goodwillincluded purchase price acquired identifiableintangibles million primarily representing customer listsand compete covenants estimatedweighted average useful life nine years financial results fordk included pharmaceutical solutions segment we acquired issued outstanding shares medconltd medcon israeli company aggregate purchaseprice million medcon provides web based cardiac image andinformation management services healthcare providersapproximately million purchase price assigned togoodwill million assigned intangibles whichrepresent technology assets customer lists table contents mckesson corporation financial notes continued anestimated weighted average useful life four years financialresults medcon included provider technologiessegment in made following acquisition investment we invested million increase ownership percentage innadro sa de cv nadro approximately prior theadditional investment company owned approximately theoutstanding common shares nadro our investment nadro accounted forunder equity method accounting within pharmaceutical solutionssegment we acquired issued outstanding sharesof moore medical corp mmc new britainconnecticut aggregate cash purchase price ofmillion mmc internet enabledmulti channel marketer distributor ofmedical surgical pharmaceutical products tonon hospital provider settings approximately million purchase price assigned togoodwill the results mmcs operations beenincluded consolidated financial statementswithin medical surgical solutions segment sincethe acquisition date during last three years also completed number smaller acquisitions andinvestments within three operating segments financial results businessacquisitions included consolidated financial statements since respectiveacquisition dates purchase prices business acquisitions allocated based onestimated fair values date acquisition certain recent acquisitions may besubject change goodwill recognized business acquisitions expected bedeductible tax purposes pro forma results operations business acquisitions havenot presented effects material consolidated financial statementson either individual aggregate basis discontinued operations results discontinued operations follows years ended march in millions income lossfrom discontinued operations acute care bioservices other income taxes total gain losson sales discontinued operations acute care bioservices other income taxes total discontinued operations net taxes acute care bioservices other total in second quarter sold medical surgical solutions segments acute caresupply business owens minor inc omi net cash proceeds approximately millionin accordance sfas no accounting impairment disposal long lived assetsthe financial results business classified discontinued operation periodspresented accompanying consolidated financial table contents mckesson corporation financial notes continued statements such presentation includes theclassification applicable assets disposed business caption prepaidexpenses applicable liabilities caption other currentliabilities within consolidated balance sheets periods presented revenues associatedwith acute care business prior disposition million million million first half financial results discontinued operation include tax loss million primarily consists tax loss million business dispositionand million tax losses associated operations asset impairment charges andemployee severance costs the tax loss million business disposition includes million non tax deductible write ofgoodwill described in connection divestiture allocated portion medical surgical solutionssegments goodwill acute care business required sfas no goodwill otherintangible assets the allocation based relative fair values acute carebusiness continuing businesses retained company the fair value ofthe acute care business determined based net cash proceeds resulting thedivestiture fair value continuing businesses determined third partyvaluation as result allocated million segments goodwill acute carebusiness additionally part divestiture entered transition services agreementtsa omi provided certain services acute care business atransition period approximately six months financial results tsa well employeeseverance charges transition period recorded part discontinued operationsthe continuing cash flows generated tsa material consolidated financialstatements tsa completed march in acute care business entered agreement third party vendor sellthe vendors proprietary software services the terms contract required us prepaycertain royalties during third quarter ended marketing sale softwareunder contract as result decision recorded million pre tax charge thethird quarter write remaining balance prepaid royalties in second quarter also sold wholly owned subsidiary pharmaceutical buyersinc pbi net cash proceeds million the divestiture resulted tax gainof million resulting tax basis subsidiary exceeding carrying valuefinancial results business previously included pharmaceutical solutionssegment presented discontinued operation periods presented theaccompanying consolidated financial statements these results material ourconsolidated financial statements the results discontinued operations also include tax gain millionassociated collection note receivable business sold sale asmall business in second quarter sold wholly owned subsidiary mckesson bioservicescorporation bioservices net cash proceeds million the divestiture resulted anafter tax gain million financial results business previously includedin pharmaceutical solutions segment presented discontinued operation allperiods presented accompanying consolidated financial statements these results notmaterial consolidated financial statements in accordance sfas no accounting impairment disposal long livedassets financial results businesses classified discontinued operations allperiods presented table contents mckesson corporation financial notes continued restructuring activities the following table summarizes activity related restructuring liabilitiesexcluding customer settlement reserves three years ended march pharmaceutical medical surgical provider solutions solutions technologies corporate exit exit exit in millions severance related severance related severance related severance total balance march expenses cash expenditures balance march expenses liabilities related toacquisition cash expenditures balance march expenses liabilities related toacquisitions cash expenditures balance march during recorded pre tax restructuring expense million primarilyreflected employee severance costs within pharmaceutical solutions providertechnologies segments there material restructuring expenses accruedrestructuring liabilities included liabilities consolidated balance sheet in connection dk acquisition recorded million liabilitiesrelating employee severance costs million facility exit contract terminationcosts approximately employees consisting primarily distribution general andadministrative staff terminated part restructuring plan to date million ofseverance million exit costs paid in connection companys investmentin parata million contract termination costs initially estimated part thedk acquisition extinguished result company decreased goodwill itsrestructuring liability at march remaining severance liability thisplan million remaining facility exit liability million anticipatedto paid various dates also connection per se acquisition recorded million employee severance liability million facility exit liability other income net years ended march in millions interest income equity earnings net other net total earnings loss per share basic earnings per share computed dividing net income lossby weighted averagenumber common shares outstanding reporting period diluted earnings lossper shareis computed similar basic earnings per share except reflects potential dilution thatcould occur dilutive securities obligations issue common stock exercised orconverted common stock for table contents mckesson corporation financial notes continued reported net loss potentially dilutivesecurities excluded per share computations due antidilutive effect the computations basic diluted earnings lossper share continuing anddiscontinued operations follows years ended march in millions except per share amounts income lossfrom continuing operations interest expense convertible junior subordinateddebentures net tax income lossfrom continuing operations diluted discontinued operations discontinued operations gain losson sales net net income loss diluted weighted average common shares outstanding basic effect dilutive securities options purchase common stock convertible junior subordinated debentures restricted stock diluted earnings lossper common share basiccontinuing operations discontinued operations discontinued operations gain losson sales net total diluted continuing operations discontinued operations discontinued operations gain losson sales net total certain computations may reflect rounding adjustments approximately million stock options excluded computations diluted netearnings per share exercise price higher companys averagestock price receivables net march in millions customer accounts other total allowances net the allowances primarily uncollectible accounts sales returns table contents mckesson corporation financial notes continued property plant equipment net march in millions land building machinery equipment total property plant equipment accumulated depreciation property plant equipment net goodwill intangible assets net changes carrying amount goodwill follows pharmaceutical medical surgical provider in millions solutions solutions technologies total balance march goodwill acquired netof purchase priceadjustments translation adjustments balance march goodwill acquired netof purchase priceadjustments translation adjustments balance march information regarding intangible assets follows march in millions customer lists technology trademarks gross intangibles accumulated amortization intangible assets net amortization expense intangible assets million million million the weighted average remaining amortization period customer liststechnology trademarks intangible assets march years years years estimated future annual amortization expense assets follows millionmillion million million million millionthereafter at march million intangible assets subject toamortization table contents mckesson corporation financial notes continued long term debt other financing march in millions seriesb senior notes due february seriesc senior notes due february notes due march notes due february notes due march notes due march debentures due march esop related debt see financial note other total debt less current portion total long term debt convertible junior subordinated debentures in february issued convertible junior subordinated debentures debenturesin aggregate principal amount million the debentures purchased mckessonfinancing trust trust proceeds issuance four million shares preferredsecurities public common securities us the debentures represented soleassets trust bore interest annual rate payable quarterly these preferredsecurities trust convertible common stock holders option holders preferred securities entitled cumulative cash distributions anannual rate liquidation amount per security each preferred security wasconvertible rate shares common stock subject adjustment certaincircumstances the preferred securities redeemed upon repayment debentures andwere callable us march whole part initially theliquidation preference per share thereafter prices declining per annum ofthe liquidation preference march plus case accumulated accrued andunpaid distributions redemption date during first quarter called redemption debentures whichresulted exchange preferred securities million shares newly issuedcommon stock other financing in january entered billion interim credit facility the interim creditfacility single draw day unsecured facility terms substantially similar tothose contained companys existing revolving credit facility we utilized billion ofthis facility fund portion purchase per se on march issued million notes due million notes due the notes unsecured interest paid semi annually march andseptember the notes redeemable time whole part option inaddition upon occurrence change control ratings downgrade notes tonon investment grade levels required make offer redeem notes price equalto principal amount plus accrued interest we utilized net proceeds offeringexpenses million issuance notes together cash hand repay allamounts outstanding interim credit facility plus accrued interest we billion five year senior unsecured revolving credit facility expires inseptember borrowings credit facility bear interest based upon either prime rateor london interbank offering rate libor we also million accounts receivablesales facility renewed june table contents mckesson corporation financial notes continued terms substantially similar thosepreviously place this renewed facility currently scheduled expire june noamounts outstanding facilities march in sold customer lease portfolio receivables cash proceeds million million million the employee stock ownership program esop debt bears interest rates ranging fixed rate approximately libor due semi annual annual installmentsthrough our various borrowing facilities certain long term debt instruments subject tocovenants our principal debt covenant debt capital ratio cannot exceed if exceed ratio repayment debt outstanding revolving credit facility million term debt could accelerated at march ratio incompliance covenants financial instruments hedging activities at march carrying amounts cash cash equivalents restrictedcash marketable securities receivables drafts accounts payable liabilitiesapproximated estimated fair values short maturity financialinstruments the carrying amounts estimated fair values long term debt million million march million million march the estimated fair value long term debt determined based quoted market prices andmay representative actual values could realized realizedin future in normal course business exposed interest rate changes foreign currencyfluctuations we limit risks use derivatives interest rate swaps andforward contracts in accordance policy derivatives used hedging purposeswe use derivatives trading speculative purposes lease obligations we lease facilities equipment capital operating leases net assets heldunder capital leases included property plant equipment million million atmarch rental expense operating leases million million andmillion we recognize rent expense straight line basis theterm lease taking account applicable lessor incentives tenant improvementsperiods rent payment required escalations rent payments term thelease deferred rent recognized difference rent expense recognized astraight line basis payments made per terms lease most real property leasescontain renewal options provisions requiring us pay property taxes operating expenses inexcess base period amounts table contents mckesson corporation financial notes continued at march future minimum lease payments sublease rental income years endingmarch non cancelable non cancelable operating sublease in millions leases rentals capital leases thereafter total minimum lease payments less amounts representing interest present value minimum lease payments pension benefits we maintain number qualified nonqualified defined benefit pension plans definedcontribution plans eligible employees as discussed financial note adopted recognition disclosure provisions sfasno required prospectively defined pension benefit plans eligible us employees employed company prior december arecovered company sponsored defined benefit retirement plan in amended planto freeze plan benefits based employees plan compensation creditable serviceaccrued date the company made annual contributions since plan frozenthe benefits defined benefit retirement plan based primarily age employees atdate retirement years service employees pay five years prior retirementwe also defined benefit pension plans eligible canadian united kingdom employees aswell nonqualified supplemental defined benefit plans certain us executives arenon funded we also assumed frozen qualified defined benefit plan acquisition ofper se the measurement date pension plans december the net periodic expense pension plans follows years ended march in millions service costbenefits earned year interest cost projected benefit obligation expected return assets amortization unrecognized actuarial lossprior service costs net transitionalobligation immediate recognition pension cost settlement charges net periodic pension expense in april made several lump sum cash payments totaling million unfundedus pension plan in accordance sfas no employers accounting settlements andcurtailments defined benefit pension plans termination benefits million insettlement charges associated payments expensed the projected unit credit method utilized measuring net periodic pension expenseover employees service life us pension plans unrecognized actuarial lossesexceeding greater projected table contents mckesson corporation financial notes benefit obligation market value assets amortized straight line averageremaining future service periods information regarding changes benefit obligations plan assets pension plansis follows march in millions change benefit obligations benefit obligation beginning year service cost interest cost actuarial losses benefit payments benefit obligations assumed acquisition foreign exchange impact benefit obligation end year change plan assets fair value plan assets beginning year actual return plan assets employer participant contributions benefits paid plan assets acquired acquisition foreign exchange impact fair value plan assets end year the accumulated benefit obligations pension plans million march million march reconciliation pension plans funded status net asset recognized asfollows years ended march in millions funded status funded status december unrecognized net actuarial loss na unrecognized net transitional obligations na unrecognized prior service cost na employer contributions subsequent measurement date amounts recognized consolidated balance sheets end year na not applicable due application sfas no table contents mckesson corporation financial notes continued amounts recognized consolidated balance sheet march follows march in millions noncurrent assets current liabilities noncurrent liabilities funded status end year accumulated comprehensive loss net tax net amounts recognized end year the components amount recognized accumulated comprehensive income asfollows march net actuarial loss net prior service cost net transitional obligation total the amounts accumulated comprehensive income expected amortized netperiodic pension expense estimate net actuarial loss net prior service cost total prior adoption sfas no additional minimum liabilities established toincrease accrued benefit cost plans totaling million million march partially offset intangible assets million million theadditional minimum liabilities charged comprehensive income included theconsolidated stockholders equity net tax sfas no adjustments recordedsee financial note significant accounting policies incremental effect applyingsfas no projected benefit obligations relating unfunded us plans million million march pension costs funded based recommendations ofindependent actuaries we expect contributions pension plans approximatelymillion expected benefit payments pension plans follows in millions expected benefit payments based assumptions used measure benefitobligations include estimated future employee service table contents mckesson corporation financial notes continued weighted average asset allocations investment portfolio pension plans atdecember target allocations follows percentage fair value total plan assets target in millions allocation assets category us equity securities international equity securities fixed income other total we develop expected long term rate return assumption based historical experienceof portfolio review projected returns asset class broad publicly tradedequity fixed income indices our target asset allocation determined based risktolerance characteristics plan times may adjusted achieve overallinvestment objective weighted average assumptions used estimate net periodic pension expense theactuarial present value benefit obligations follows net periodic expense discount rates rate increase compensation expected long term rate return plan assets benefit obligation discount rates rate increase compensation expected long term rate return plan assets other defined benefit plans under various us bargaining unit labor contracts make payments multi employerpension plans established union employees we liable proportionate part theplans unfunded vested benefits liabilities upon withdrawal plan however informationregarding relative position employer respect actuarial present value ofaccumulated benefits net assets available benefits available contributions theplans amounts accrued material years ended march defined contribution plans we contributory profit sharing investment plan psip us employees coveredby collective bargaining arrangements eligible employees may contribute theircompensation individual retirement savings account effective april companymakes matching contributions amount equal employees first pay deferredand employees deferral next pay deferred the company provides thepsip contributions primarily common shares leveraged esop cash payments the esop purchased aggregate million shares companys common stock since itsinception these purchases financed year loans guaranteed us theesops outstanding borrowings reported long term debt company relatedreceivables esop shown reduction stockholders equity the loans repaidby esop interest earnings cash balances common dividends shares yetallocated participants common dividends certain allocated shares table contents mckesson corporation financial notes continued company cash contributions the esop loan maturities rates identical terms ofrelated company borrowings stock made available esop based debt service paymentson esop borrowings contribution expense psip primarily esop relatedafter tax esop expense contribution expense including interest expense esop debt wasmillion million million approximately million shares ofcommon stock allocated plan participants years throughmarch million common shares allocated plan participants resulting abalance million common shares esop yet allocated planparticipants postretirement benefits we maintain number postretirement benefits primarily consisting healthcare lifeinsurance welfare benefits certain eligible us employees eligible employees consist ofthose retired march retire march anactive employee date meeting age related criteria we also providepostretirement benefits certain us executives the measurement date postretirementwelfare plan december as discussed financial note significant accounting policies adopted therecognition disclosure provisions sfas no required prospectively the net periodic expense postretirement welfare benefits follows years ended march in millions service costbenefits earned year interest cost projected benefit obligation amortization unrecognized actuarial lossand prior service costs net periodic postretirement expense information regarding changes benefit obligations postretirement welfare plansis follows years ended march in millions change benefit obligations benefit obligation beginning year service cost interest cost actuarial loss gain benefit payments benefit obligation end year amounts recognized consolidated balance sheet march follows years ended march in millions funded status funded status end year unrecognized net actuarial loss na unrecognized prior service cost na liabilities recognized consolidatedbalance sheet including current portion ofmillion million na not applicable due application sfas no table contents mckesson corporation financial notes continued the components amount recognized accumulated comprehensive income asfollows march net actuarial gain net prior service credit total the amount accumulated comprehensive income expected amortized netperiodic post retirement expense approximately million representing net actuarial loss other postretirement benefits funded claims paid expected benefit payments forour postretirement welfare benefit plans net expected medicare subsidy receipts millionare follows in millions expected benefit payments based assumptions used measure benefitobligations include estimated future employee service weighted average assumptions used estimate postretirement welfare benefit expenses theactuarial present value benefit obligations follows net periodic expense discount rates benefit obligation discount rates actuarial gain loss postretirement welfare benefit plan amortized income overa three year period the assumed healthcare cost trends used measuring accumulatedpostretirement benefit obligation prescription drugs medicaland dental the healthcare cost trend rate assumption asignificant effect amounts reported for one percentage pointincrease one percentage point decrease assumed healthcare cost trend rate would impacttotal service interest cost components approximately million postretirementbenefit obligation approximately million million table contents mckesson corporation financial notes continued income taxes the provision benefitfor income taxes related continuing operations consists thefollowing years ended march in millions current federal state local foreign total current deferred federal state local foreign total deferred income tax provision benefit in second quarter recorded credit current income tax expense million primarily pertains receipt private letter ruling us internalrevenue service holding payment approximately million settle securitieslitigation consolidated action fully tax deductible we previously established tax reserves toreflect lack certainty regarding tax deductibility settlement amounts paid theconsolidated action related litigation also recorded million income tax benefits arising primarily fromsettlements adjustments various taxing authorities research development investmenttax credits canadian operations in march made million payment escrow account relating thesecurities litigation described detail financial note other commitments andcontingent liabilities this payment deducted income tax returns resultour current tax expense decreased deferred tax expense increased primarilyreflecting utilization deferred tax assets associated securities litigationin recorded million income tax expense primarily relates basis adjustmentin investment adjustments various taxing authorities in recorded income tax benefit million securities litigation whichis described detail financial note we believed settlement consolidatedsecurities class action ultimate resolution lawsuits brought independently othershareholders would tax deductible however tax attributes litigation complexand company expected challenges taxing authorities accordingly deductionswould finalized lawsuits concluded examination companys taxreturns completed accordingly march provided tax reserves futureresolution uncertain tax matters in recorded million income tax benefit arising primarily settlements andadjustments various taxing authorities million income tax benefit primarily due areduction valuation allowance related state income tax net operating loss carryforwardswe believed income tax benefit portion state net operating losscarryforwards would realized our income tax expense deferred tax assets liabilities reflect managements bestassessment estimated future taxes paid we subject income taxes usand numerous foreign jurisdictions significant judgments estimates required indetermining consolidated income tax provision table contents mckesson corporation financial notes continued the reconciliation companys effective tax rate income continuingoperations statutory tax rate follows years ended march in millions income tax provision benefitat federal statutory rate state local income taxes net federal tax benefit foreign tax rate differential securities litigation reserve nondeductiblenontaxable items tax settlements othernet income tax provision benefit foreign pre tax earnings million million million at march undistributed earnings foreign operations totaling millionwere considered permanently reinvested no deferred tax liability recognized forthe remittance earnings us since intention utilize earnings inthe foreign operations well fund certain research development activities anindefinite period time repatriate earnings tax efficient thedetermination amount deferred taxes earnings practicable since thecomputation would depend number factors cannot known decision repatriatethe earnings made deferred tax balances consisted following march in millions assets receivable allowances deferred revenue compensation benefit related accruals securities litigation loss credit carryforwards other subtotal less valuation allowance total assets liabilities basis differences inventory valuation andother assets basis difference fixed assets systemsdevelopment costs intangibles other total liabilities net deferred tax liability current net deferred tax liability long term net deferred tax asset net deferred tax liability we income tax net operating loss carryforwards related international operations ofapproximately million indefinite life we federal state income tax net operating loss carryforwards million andmillion expire various dates we believe ismore likely benefit certain state net operating loss carryforwards nowbe realized in recognition risk haveprovided valuation allowance million deferred tax assets relating thesestate net operating loss carryforwards table contents mckesson corporation financial notes continued wealso domestic income tax credit carryforwards million primarily alternativeminimum tax credit carryforwards indefinite life foreign income tax credit carryforwards million whichare canadian research development credit carryforwards thatexpire in reversed portion valuation allowance related state netoperating loss carryforwards million tax benefit net impairment wascredited equity financial guarantees warranties financial guarantees we agreements certain customers financial institutions haveguaranteed repurchase inventory primarily canadian business discount theevent customers unable meet certain obligations financial institutionsamong requirements inventories must resalable condition we alsoguaranteed loans credit facilities customers secured lender forsubstantially guarantees customer guarantees range one seven years wereprimarily provided facilitate financing certain strategic customers at march theamounts inventory repurchase guarantees customer guarantees million million nominal amount accrued in pharmaceutical solutions customer filed bankruptcy in converted amillion credit facility guarantee favor customer note receivable due thiscustomer this secured note bore interest repayable in conjunction thismodification inventory repurchase guarantee favor customer approximately million also terminated in second quarter term note amended andthe note repayable the amount due note receivable customer wasapproximately million march at march commitments million cash contributions equity heldinvestments amounts accrued the expirations noted financial guarantees commitments follows million million nil million nil million thereafter in addition banks insurance companies issued million standby letters ofcredit surety bonds behalf order meet security requirements statutorylicenses permits court fiduciary obligations workers compensation automotiveliability programs our software license agreements generally include certain provisions indemnifyingcustomers liabilities software products infringe third partys intellectualproperty rights to date incurred material costs result suchindemnification agreements accrued liabilities related obligations in conjunction certain transactions primarily divestitures may provide routineindemnification agreements retention previously existing environmental tax andemployee liabilities whose terms vary duration often explicitly defined whereappropriate obligations indemnifications recorded liabilities because theamounts indemnification obligations often explicitly stated overall maximumamount commitments cannot reasonably estimated other obligations recorded asliabilities time divestiture historically made significant payments aresult indemnification provisions warranties in normal course business provide certain warranties indemnification protectionfor products services for example provide warranties pharmaceutical andmedical surgical products distribute compliance food drug cosmetic act andother applicable laws regulations we received warranties supplierswhich customarily manufacturers products in table contents mckesson corporation financial notes continued addition indemnity obligations customers products also beenprovided us suppliers either express agreement operation law we also provide warranties regarding performance software automation products wesell our liability warranties bring product compliance previouslyagreed upon specifications for software products may result additional project costswhich reflected estimates used percentage completion method accounting forsoftware installation services within contracts in addition customers whopurchase software automation products also purchase annual maintenance agreements revenuefrom maintenance agreements recognized straight line basis contract periodand cost servicing product warranties charged expense claims become estimableaccrued warranty costs material consolidated balance sheets other commitments contingent liabilities iaccounting litigation following announcements mckesson april may july mckesson haddetermined certain software sales transactions information solutions segment formerlyhbo company known mckesson information solutions llc improperly recorded asrevenue reversed march ninety two lawsuits filed mckessonhboc certain mckessons hbocs current former officers directors otherdefendants including bear stearns co inc bear stearns arthur andersen llpandersen on january announced reached agreement settle thepreviously reported action northern district california captioned in mckesson hbocinc securities litigation noc rmw consolidated action in general weagreed pay settlement class total million cash during third quarter recorded million pre tax million tax charge respect thecompanys securities litigation the charge consisted million consolidated actionand million securities litigation proceedings during settled many securities litigation proceedings paid million pursuant settlements based payments made consolidated action andthe securities litigation proceedings settlements reached certain securitieslitigation proceedings assessment remaining cases estimated reserves wereincreased million million pre tax charges first third quarters decreased million pre tax credit fourth quarter totalnet pre tax charge million on february court gave final approval tothe settlement consolidated action result paid approximately million intoan escrow account established lead plaintiff connection settlement during securities litigation accrual decreased million primarily reflecting anet pre tax credit million representing settlement reassessment another case inthe second quarter million cash payments made connection thesesettlements based payments made consolidated action payments made settle otherpreviously reported securities litigation proceedings based assessment remainingcases estimated securities litigation accruals march million million we believe accrual adequate address remaining potentialexposure respect securities litigation matters however view numberand uncertainties timing outcome type litigation substantial amountsinvolved possible ultimate costs matters could impact earnings eithernegatively positively quarter resolution we believe theresolution matters material adverse effect results operationsliquidity financial position taken whole although securities litigation cases resolved reported andpreviously certain matters remain pending fully described table contents mckesson corporation financial notes continued federal actions on february honorable ronald whyte signed final judgment order ofdismissal judgment court gave final approval settlement theconsolidated action dismissed merits prejudice claims asserted theconsolidated action company hboc defendants released persons term isdefined judgment on march defendant bear stearns filed appeal thejudgment united states court appeals ninth circuit the appeal bear stearnschallenges certain provisions settlement restrict bear stearns ability bringcertain claims future company hboc certain persons released thesettlement the appeal fully briefed parties awaiting notice hearing date forargument appeal we believe outcome bear stearns appeal affectour right ability enjoy benefits settlement including releases thecompany hboc defendants released persons term defined stipulation ofsettlement members settlement class on march paid approximately million escrow account established inconnection settlement consolidated action full satisfaction paymentobligations judgment stipulation settlement any distribution fundsdeposited escrow account class members subject prior court approval we showamounts paid escrow account future distribution class members securitieslitigation settlement restricted cash corresponding liability current liabilitiesunder caption securities litigation the liability discharged time thesettlement declared effective court on september judge whyte granted final approval previously reported agreementto settle claims brought employee retirement income security act erisa onbehalf former participants mckesson profit sharing investment plan million in remckesson hboc inc erisa litigation noc rmw the period appeal thatapproval order expired settlement dismissal action final the previously reported action captioned cater mckesson corporation et al noc rmw remaining individual action pending federal court there beenno discovery activity action since original filing on august company hboc filed complaint andersen formerandersen partner robert putnam putnam san francisco superior court captioned mckessoncorporation et al andersen et al no putnam subsequently removed theunited states district court northern district california upon removal case wasassigned judge whyte given nd cal case no rmw in complaint amended onmarch mckesson asserts claims andersen negligent misrepresentation breach ofcontract equitable indemnity declaratory relief contribution hboc asserts claimsagainst andersen breach contract professional negligence equitable indemnity ordeclaratory relief contribution mckesson hboc also assert claims putnam forequitable indemnity declaratory relief contribution connection andersens auditsand reviews hbocs financial results the complaint seeks unspecified damagesvarious forms equitable declaratory relief costs suit attorneys fees on march andersen filed action mckesson hboc federal court san jose captioned andersen mckesson corporation et al noc jw in complaint andersen assertsclaims mckesson hboc fraud negligent misrepresentation breach contract breachof covenant good faith fair dealing equitable indemnity declaratory relief inconnection andersens prior audits reviews hbocs financial results the complaintseeks unspecified damages including punitive damages unspecified amount declaratory reliefand costs suit both andersen filed september argued motions todismiss one anothers complaints actions parties awaiting judge whytesrulings motions state actions twenty four actions filed various state courts california colorado delawaregeorgia louisiana pennsylvania state actions like consolidated action stateactions generally allegemisconduct mckesson hboc others connection events leading tomckessons decision restate hbocs financial statements all actions settled orotherwise resolved march table contents mckesson corporation financial notes continued except following individual actions pending georgia holcombe tgreen htg corp mckesson inc et al georgia superior court fulton county case no cv hall family investments lp mckesson inc et al georgia superior courtfulton county case no cv james gilbert mckesson corporation et al georgiastate court fulton county case novsc the allegations actions aresubstantially similar consolidated action the company hboc answered thecomplaints actions generally denying allegations liability toplaintiffs the green hall family investments lp actions voluntarily dismissed byplaintiffs april georgia superior court filed georgia statecourt fulton county holcombe green htg corp mckesson corporation et al georgia statecourt fulton county case no vs hall family investments lp mckessoncorporation et al georgia state court fulton county case no vs plaintiffsthere allege claims fraud deceit additionally plaintiff green seeks indemnification inconnection erisa action unspecified losses in april filedmotions disqualify green hall family investments lp damages experts summaryjudgment plaintiffs cases filed counter motions summary judgment whichmotions scheduled argued june no trial date set thosecases the gilbert action asserted claims fraud deceit negligent misrepresentationclaims hboc mckesson settled january in december bear stearns filed complaint captioned bear stearns co inc vmckesson corporation case no company trial court state andcounty new york bear stearns alleges companys entry settlement theconsolidated action without providing full release bear stearns settlement abreach engagement letter bear stearns advised company connection itsacquisition hboc bear stearns complaint seeks monetary relief including orderenjoining company performing settlement agreement this objection madeby bear stearns opposition preliminary final approvals class actionsettlement the objection rejected judge whyte grounds denying approval thesettlement september order granting preliminary approval february order granting final approval discovery continuing action no trial date hasbeen set iiother litigation claims in addition commitments obligations ordinary course business subjectto various claims pending potential legal actions product liability otherdamages investigations relating governmental laws regulations matters arising outof normal conduct business these include product liability litigation other claims the company defendant approximately cases alleging plaintiffs wereinjured vioxx anti inflammatory drug manufactured merck company merck the casestypically assert causes action strict liability negligence breach warranty falseadvertising improper design testing manufacturing warnings relating manufactureand distribution vioxx none cases involving company scheduled trial thecompany tendered cases merck reached agreement merck defendand indemnify company the company defendant approximately cases alleging plaintiffs injuredbecause took drugs known fen phen term commonly used describe weight losscombination fenfluramine dexfenfluramine phentermine the company named adefendant along several defendants cases accepted tender one itscustomers named defendant one additional case the cases pending state courts incalifornia mississippi state federal courts florida new york typicallyassert causes action strict liability negligence breach warranty false advertising andunfair business practices improper design testing manufacturing warnings relating thedistribution andor prescription fen phen the company tendered cases itssuppliers reached agreement major supplier defend indemnify companyand customers table contents mckesson corporation financial notes continued we former mckesson chemical company division named approximately cases involving alleged distribution asbestos these cases typically involve either singleor multiple plaintiffs claiming personal injuries unspecified compensatory punitive damagesas result exposure asbestos containing materials pursuant indemnification agreementsigned time sale mckesson chemical company called univar usainc univar tendered actions univar univar raised questionsconcerning extent obligations indemnification agreement univarcontinues defend us many cases rejecting tenders new cases sincefebruary we believe univar remains obligated tendered cases terms theindemnification agreement however continue incur defense costs connection morerecently served actions we also believe portion claims us coveredby insurance pursuing available coverage on may judgment entered us one employees action roby vmckesson hboc inc et al superior court yolo county california case nocv formeremployee charlene roby roby brought claims wrongful termination disability discriminationand disability based harassment mckesson claim disability based harassmentagainst former supervisor the jury awarded roby compensatory damages mckesson andagainst supervisor total amount million punitive damages amount million mckesson following post trial motions trial court reduced amount ofcompensatory damages mckesson million punitive damages awarded bothdefendants compensatory damages awarded individual employee defendant notreduced we filed notice appeal seeking reduction reversal compensatory andpunitive damage awards award attorneys fees on december court appealfor third appellate district issued decision reversing verdict harassment againstrobys supervisor reducing compensatory damages million million punitivedamages million million following rejection robys petition rehearingbefore court appeals plaintiff petitioned review california supreme court whichwas granted april we answer petition seek order supremecourt upholding court appeals decision on february class action complaint filed united states district courtfor eastern district missouri acquired subsidiary dk dks formerchief executive operating financial officers alleging breach fiduciary duties andviolations sections securities exchange act ruleb garydutton dk healthcare resources inc et al case no cv snl the commercialworkers union local afl cio food employees joint pension plan lead plaintiff thataction sought represent class consisting purchasers dks publicly traded common stockduring period august september sought compensatory damagescosts fees expenses suit the action generally alleges dk failed timely disclosethat sales branded drugs class period heavily dependent itsability purchase drugs vendor bristol myers squibb company bms discounted prices andin volume defendants knew disclose effect losing attractivepurchase terms bms would material reduction sales volume profit on february entered settlement agreement resolves claims dk shareholdersagainst defendants we obligated terms agreement pay million butanticipate recouping million amount dks insurer the settlement received thepreliminary approval trial court remains subject various conditions including finalapproval trial court presently scheduled argued june on june civil class action complaint filed us united statesdistrict court district massachusetts new england carpenters health benefits fund et al vfirst databank inc mckesson corporation civil action no alleging thatcommencing late early co defendant first databank fdb agreed takeactions increase average wholesale price awp certain branded drugs allegedconduct resulted higher drug reimbursement payments plaintiffs others similarly situatedthe complaint purports state claims based federal racketeer influenced corruptorganizations act rico violations california business professions code andcalifornia consumers legal remedies act negligent misrepresentation the plaintiffs seekinjunctive relief well compensatory punitive damages attorneys fees costs onoctober plaintiffs co defendant fdb announced proposed settlement fdbonly calls downward adjustments certain fdbpublished awps prohibition future changes awps prescribedtimetable cessation publication awps fdb in november courtgranted preliminary approval table contents mckesson corporation financial notes continued settlement although certain restrictions type class could utilized toeffect settlement the court yet approved form class notice set schedule forobjections settlement set date hearing final approval on may thecourt scheduled hear plaintiffs petition class certification objections tocertification we answered complaint matter discovery no trial date hasbeen set on july action filed united states district court easterndistrict new york mckesson two mckesson employees four drug wholesalers andsixteen drug manufacturers rxusa alcon laboratories et al case no cv mjtplaintiff alleges along various defendants unlawfully engaged inmonopolization attempted monopolization sale distribution pharmaceutical productsin violation federal antitrust laws well violation new york states donnellyact we also alleged violated sarbanes oxley act employees arealleged violated donnelly act sarbanes oxley act sections cand dofthe civil rico statute plaintiff alleges generally defendants individually inconcert one another taken actions create maintain monopoly exclude secondarywholesalers plaintiff wholesale pharmaceutical industry the complaintseeks monetary damages including treble damages attorneys fees injunctive relief all defendants filed motions todismiss claims no date hearing motions set discovery commencedno trial date set between former chemical company division operated facility santa fesprings california we actively remediating contamination site since angeles chemical company angeles conducted similar chemical repackaging activities itsproperty adjacent companys site in late angeles filed anaction mckesson angeles chemical company mckesson corporation et al united statesdistrict court central district california case no tjh claiming itscontamination migrated angeles property the causes action currentcomplaint purport state claims based comprehensive environmental response compensationand liability act resource conservation recovery act well fornegligence trespass equitable indemnity defamation nuisance interference prospectiveadvantage violations california business professions code angeles seeksinjunctive relief well compensatory punitive damages attorneys fees costs wehave responded complaint matter discovery no trial date set we responded tothe complaint andsubstantial discovery conducted allparties the trail court recently extended discovery cut datein matter june pretrial conference isscheduled october time trial date expectedto set the health care industry highly regulated government agencies continue increasetheir scrutiny certain practices affecting government programs from time time thecompany receives subpoenas requests information various government agencies thecompany generally responds subpoenas requests cooperative thorough timelymanner these responses sometimes require considerable time effort result inconsiderable costs incurred company examples requests subpoenas includethe following received subpoena us attorneys office usao inmassachusetts seeking documents relating companys business relationship long termcare pharmacy organization process responding subpoena haveresponded request federal trade commission certain documents part anon public investigation determine whether company may engaged anti competitivepractices wholesale pharmaceutical distributors order limit competition forprovider customers seeking distribution services received civil investigative demandcid attorney generals office state tennessee apparently connection withan investigation possible violations tennessee medicaid false claims act connectionwith repackaged pharmaceuticals process responding subpoena wehave responded subpoena office attorney general state new yorknyag requesting documents information concerning participation secondaryor alternative source market pharmaceutical products also received subpoenafrom nyag relating pricing certain drugs including first databank averagewholesale average benchmark prices drugs responded subpoena andotherwise cooperated nyag advised investigation usaofor northern district mississippi whether intervene civil qui tam actionfiled unknown private relator company defendants informedthat action purports allege violations anti kickback statute connection theprovision medicare claims billing services anaffiliate multi facility nursing home customer we seen civil complaintthat subject investigation provided documents usao fullycooperating investigation table contents mckesson corporation financial notes continued because investigations concluded cannot predict outcome impact ofthese proceedings business as previously reported january acquired per se time per se became awholly owned subsidiary mckesson prior acquisition per se publicly disclosed twosec investigations knowledge closed those investigations thefollowing in march sec issued subpoena per se pursuant formal order ofinvestigation believe relates allegations wrongdoing made former per seemployee those allegations subject prior investigation per se auditcommittee outside accounting firm per se produced documents provided testimony tothe sec there recent activity matter sec taken action againstper se date in december sec issued formal order investigation relatingto accounting matters ndchealth corporation ndchealth public company wasacquired per se january prior acquisition per se in march ndchealth restated financial statements fiscal years ended may may may fiscal quarters ended august august correcterrors relating certain accounting matters ndchealth produced documents sec fullycooperated sec investigation the sec taken testimony number currentand former ndchealth employees there recent activity matter sec hastaken action ndchealth successor date environmental matters primarily result operation former chemical businesses fullydivested involved various matters pursuant environmental laws andregulations we received claims demands governmental agencies relating toinvestigative remedial actions purportedly required address environmental conditions allegedto exist seven sites entities acquired us formerly conducted operations weby administrative order otherwise agreed take certain actions sites includingsoil groundwater remediation in addition one multiple recipients new jerseydepartment environmental protection agency directive separate united states environmentalprotection agency directive relating potential natural resources damages nrd associated withone seven sites although companys potential allocation either directive cannotbe determined time agreed participate potentially responsible partyprp group funding nrd assessment costs reflected theaggregate estimates set forth based determination environmental staff consultation outsideenvironmental specialists counsel current estimate reasonably possible remediationcosts five sites million net approximately million third parties haveagreed pay settlement expect based either agreements nonrefundable contributionswhich ongoing contributed third parties the million expected paid outbetween april march our estimated liability environmental matters hasbeen accrued accompanying consolidated balance sheets in addition designated prp comprehensive environmentalcompensation liability act amended superfund law state lawequivalent environmental assessment cleanup costs result alleged disposal ofhazardous substances sites with respect sites numerous prps havesimilarly designated current state law potentially imposes joint andseveral liability upon prps practical matter costs sites typically shared withother prps our estimated liability sites approximately million the aggregatesettlements costs paid us superfund matters date significant theaccompanying consolidated balance sheets include environmental liability the potential costs us related environmental matters uncertain due factorsas unknown magnitude possible pollution cleanup costs complexity evolvingnature governmental laws regulations interpretations timing varying costsand effectiveness alternative cleanup technologies determination liability inproportion prps extent costs recoverable frominsurance parties while possible determine certainty ultimate outcome duration ofany litigation governmental proceedings discussed section ii otherlitigation claims believe based table contents mckesson corporation financial notes continued current knowledge advice counsel litigation proceedings havea material adverse effect financial position results operations cash flows stockholders equity each share companys outstanding common stock permitted one vote proposalspresented stockholders entitled share equally dividends declared thecompanys board directors board the board approved share repurchase plans october august december andjanuary permitted company repurchase total billion millionper plan companys common stock under plans repurchased million shares formillion made repurchases as march less million remained available future repurchases january plan theseother plans completed in april july board approved two new share repurchase plans permitted thecompany repurchase additional billion million per plan companyscommon stock during repurchased total million shares billion as aresult repurchases effectively completed share repurchase plans on april board approved additional share repurchase plan billion companys common stock repurchased shares used support stock based employee compensation plans othergeneral corporate purposes stock repurchases may made time time open market orprivate transactions in stockholders approved new stock plan stock plan allows forthe grant options restricted stock restricted stock units stock appreciation rightsperformance shares share based awards employees officers directors thecompany the stock plan replaced several plans legacy plans remainingmillion shares available issuance legacy plans cancelled although awardsunder plans remain outstanding under stock plan million new shares wereauthorized issuance march million shares remain available grant asa result acquisitions currently option plans awards havebeen made since date acquisition in board renewed companys common stock rights plan under renewal theplan effective october board declared dividend distribution one right aright outstanding share company common stock the common stock rights plan wasstructured certain antitakeover effects would cause substantial dilution theownership interest person group attempted acquire company terms approvedby board on january board amended common stock rights plan provide forthe termination rights plan effective january the company also employee stock purchase plan espp million shareshave authorized issuance eligible employees may purchase limited number shares ofthe companys common stock discount market value certain plan defineddates in million million million shares issued theespp at march million shares available issuance espp as previously discussed first quarter called redemption thedebentures resulted exchange preferred securities million shares ournewly issued common stock share based payment we provide share based compensation employees officers non employee directorsincluding stock options employee stock purchase plan restricted stock rs restricted stockunits rsus performance table contents mckesson corporation financial notes continued based restricted stock units persus collectively share based awards on april weadopted sfas nor discussed financial note significant accounting policiesaccordingly began recognize compensation expense fair value share based awardsgranted modified repurchased cancelled april forward compensation expense isrecognized portion awards ultimately expected vest for unvestedportion awards issued prior outstanding april expense recognized atthe grant date fair value remaining requisite service rendered we recognizecompensation expense straight line basis requisite service period awardswith graded vesting service conditions for awards performance conditions werecognize expense straight line basis treating vesting tranche separate award we adopted sfas nor using modified prospective method therefore notrestated prior period financial statements prior adopting sfas nor accounted forour employee share based compensation plans using intrinsic value method apb opinion no this standard generally require recognition compensation expense majorityof share based awards except rs rsus in addition required apb opinion no previously recognized forfeitures occurred we develop estimate number share based awards ultimately vestprimarily based historical experiences the estimated forfeiture rate established upon grant isre assessed periodically throughout requisite service period such estimates revised ifthey differ materially actual forfeitures as required forfeiture estimates beadjusted reflect actual forfeitures award vests the actual forfeitures futurereporting periods could materially higher lower current estimates theweighted average forfeiture rate approximately as resultthe future share based compensationexpense may differ companys historical amounts the compensation expense recognized sfas nor classified incomestatement capitalized balance sheet manner cash compensation paid ouremployees there material share based compensation expense capitalized part thebalance sheet march in addition sfas nor requires benefits ofrealized tax deductions excess previously recognized tax benefits compensation expense bereported financing cash flow rather operating cash flow done apb opinionno for year ended march million excess tax benefits recognized in conjunction adoption sfas nor first quarter electedthe short cut method calculating beginning balance additional paid capital poolapic pool related tax effects share based compensation under method asimplified calculation applied establishing beginning apic pool balance well asdetermining future impact apic pool consolidated statements cash flowsrelating tax effects share based compensation the election accounting policydid material impact consolidated financial statements table contents mckesson corporation financial notes continued impact net income the components share based compensation expense related tax benefit shown inthe following table years ended march in millions except per share amounts rsu rs persu stock options employee stock purchase plan share based compensation expense tax benefit share based compensation expense share base compensation expense net tax impact share based compensation earnings per share diluted basic no material share based compensation expense included discontinued operations isfas no pro forma information as described financial note prior april accounted employeeshare based compensation plans using intrinsic value method apb opinion no hadcompensation expense employee share based compensation recognized based fairvalue method consistent provisions sfas no net income earnings per sharewould follows years ended march in millions except per share amounts net income loss reported compensation expense net tax apb opinion no expense included net income sfas no expense pro forma net income loss earnings lossper common share diluted reported diluted pro forma basic reported basic pro forma in granted million million employee stock options substantially allof vested march the shortened vesting schedules grantwere approved compensation committee companys board directors compensationcommittee employee retention purposes anticipation requirements sfas nor prior stock options typically vested four year period accordingly sfasno compensation expense employee stock options fully vestedprior april reflected pro forma results recognized ourearnings adoption sfas nor iistock plans the plan provides employees officers non employee directors share basedlong term incentives the plan permits granting stock options rs rsus persus andother share based awards under plan million shares authorized issuance andas march million shares remain available future grant the plan replacedthe following three plans advance expirations stock option restricted stockplan directors equity compensation deferral plan table contents mckesson corporation financial notes continued canadian incentive plan collectively legacy plans the aggregate remaining million authorized shares legacy plans cancelled although awards plansremain outstanding the plan companys plan providing share basedincentive compensation employees non employee directors company affiliates in anticipation requirements sfas nor compensation committee reviewedour long term compensation program key employees across company as result beginning reliance options reduced long term incentive value delivered grants ofpersus performance based cash compensation iii stock options stock options granted less fair market value options granted underthe plan contractual term seven years prior stock options typicallyvested four year period contractual term ten years as noted provided shortened vesting schedules employee stock options upongrant options granted seven year contractual life generally follow thefour year vesting schedule we expect option grants future years samecontractual life vesting schedule option grants stock options legacy planswhich substantially vested generally ten year contractual life compensation expense stock options recognized straight line basis therequisite service period based grant date fair value portion awardsthat ultimately expected vest we continue use black scholes model estimate thefair value stock options once fair value employee stock option value isdetermined current accounting practices permit changed even estimates usedare different actual the option pricing model requires use various estimates andassumptions follows expected stock price volatility based combination historical volatility common stock impliedmarket volatility we believe market based input provides better estimate future stock pricemovements consistent emerging employee stock option valuation considerations our expected stock pricevolatility assumption continues reflect constant dividend yield expected term option expected dividend yield based historical experience investors current expectations the risk free interest rate periods within expected life option based constant maturity ustreasury rate effect time grant the expected life options determined based historical option exercise behavior data also reflects theimpact changes contractual life current option grants compared historical grants weighted average assumptions used estimate fair value employee stock options asfollows years ended march expected stock price volatility expected dividend yield risk free interest rate expected life years table contents mckesson corporation financial notes continued the following summary options outstanding march options outstanding options exercisable number weighted number options average weighted options outstanding at remaining average exercisable weighted range exercise year end contractual life exercise year end average prices in millions years price in millions exercise price the following table summarizes stock option activity weighted average weighted remaining aggregate average exercise contractual intrinsic in millions except per share data shares price term years value outstanding march granted exercised cancelled forfeited outstanding march granted exercised cancelled forfeited outstanding march granted exercised outstanding march vested expected vest march exercisable march the number options expected vest takes account estimate expectedforfeitures the aggregate intrinsic value calculated difference period end marketprice companys common stock option exercise price times number ofin money option shares table contents mckesson corporation financial notes continued the following table provides data related stock option activity years ended march in millions weighted average grant date fair value per stock option aggregate intrinsic value exercise cash received upon exercise tax benefits realized related exercise total fair value shares vested total compensation cost net estimated forfeituresrelated unvested stock options yet recognizedpre tax na na weighted average period years stockoption compensation cost expected recognized na na na not applicable stock optioncompensation cost generallyrecognized apb opinion no ivrs rsus persus rs rsus entitle holder receive end vesting term specifiednumber shares companys common stock accounted fair value date ofgrant the fair value rs rsus stock plans determined product thenumber shares expected vest grant date market price companys commonstock the compensation committee determines vesting terms time grant these awardsgenerally vest two five years the fair value rs rsus graded vesting serviceconditions expensed straight line basis requisite service period rs containscertain restrictions transferability may transferred restrictions lapse each non employee director currently receives rsus annually vest immediately andwhich expensed upon grant however issuance shares delayed director nolonger performing services company at march rsus directors arevested shares issued persus rsus number rsus awarded may conditional upon attainment ofone performance objectives specified period vesting awards ranges oneto three year periods following end performance period may follow graded orcliff method vesting persus accounted variable awards performance goals reached thegrant date established the fair value persus determined product number ofshares eligible awarded expected vest market price companys commonstock commencing inception requisite service period during performance periodthe persus valued using market price performance modifier end areporting period at end performance period goals attained award isclassified rsu accounted basis the fair value persus expensed astraight line basis treating vesting tranche separate award requisite serviceperiod four years for rs rsus service conditions elected amortize theexpense straight line basis table contents mckesson corporation financial notes continued the following table summarizes rs rsu activity weighted average grant date fair in millions except per share data shares value per share nonvested march granted nonvested march granted nonvested march granted nonvested march the following table provides data related rs rsu activity years ended march in millions total fair value shares vested total compensation cost net ofestimated forfeitures related tononvested rsu awards yetrecognized pre tax weighted average period years overwhich rsu cost expected berecognized compensation cost reflect forfeiture assumptions requiredunder apb opinion no in may compensation committee approved million persu target share unitsrepresenting base number awards could granted goals attained would begranted first quarter persu these target share units includedin table granted form rsu as march thetotal compensation cost net estimated forfeitures related nonvested persus yetrecognized approximately million pre tax based period end market price thecompanys common stock weighted average period cost expected berecognized years in accordance provisions sfas no earnings per share persus areincluded calculation diluted weighted average shares year ended march asthe performance goals achieved vemployee stock purchase plan espp the espp allows eligible employees purchase shares common stock payrolldeductions the deductions occur three month purchase periods shares thenpurchased market price end purchase period employees allowed toterminate participation espp time purchase period prior thepurchase shares amounts accumulated period refunded the discount provided employees shares included compensation expensethe funds outstanding end quarter included calculation diluted weightedaverage shares outstanding these amounts significant table contents mckesson corporation financial notes continued related party balances transactions notes receivable outstanding certain current former officers seniormanagers totaled million million march these notes related topurchases common stock various employee stock purchase plans the notes bear interestat rates ranging due various dates february interestincome notes recognized extent cash received these notes whichare included capital consolidated balance sheets issued amounts equal tothe market value stock date purchase full recourse borrowerat march value underlying stock collateral million thecollectability notes evaluated ongoing basis as result recorded netcredits million million million based changes priceof underlying stock collateral at march provided reserve ofapproximately million million outstanding notes other receivable balances heldwith related parties consisting loans made certain officers senior managers anequity held investment march amounted million in incurred approximately million million annually rentalexpense paid equity held investment in addition purchased million services per year equity held investment at march million loan receivable equity held investment the loan bears interest segments business our segments include pharmaceutical solutions medical surgical solutions providertechnologies we evaluate performance operating segments based operating profitbefore interest expense income taxes results discontinued operations our corporatesegment includes expenses associated corporate functions projects certain employeebenefits results certain joint venture investments corporate expenses allocatedto operating segments extent items directly attributable thesegment table contents mckesson corporation financial notes continued financial information relating reportable operating segments presented years ended march in millions revenues pharmaceutical solutions medical surgical solutions provider technologies software software systems services hardware total provider technologies total operating profit pharmaceutical solutions medical surgical solutions provider technologies total corporate securities litigation charge credit interest expense income lossfrom continuing operations beforeincome taxes depreciation amortization pharmaceutical solutions medical surgical solutions provider technologies corporate total expenditures long lived assets pharmaceutical solutions medical surgical solutions provider technologies corporate total segment assets year end pharmaceutical solutions medical surgical solutions provider technologies total corporate cash cash equivalents other total in addition distribution pharmaceutical healthcare products ourpharmaceutical solutions segment revenues include disease management patient servicesfor payors software consulting outsourcing pharmacies revenuesfrom products services material component segment revenues in addition revenues derived services represent less thissegments revenues includes million million million net earnings equity investments operating profit includes million million millionrepresenting share settlements antitrust class action lawsuits brought againstcertain drug manufacturers these settlements recorded reductions cost saleswithin consolidated statements operations pharmaceutical solutions segment operating profit includes million credit income due adjustment alegal reserve includes million credit income due recovery apreviously reserved customer account includes amortization intangibles capitalized software held sale capitalizedsoftware internal use long lived assets consist property plant equipment table contents mckesson corporation financial notes continued revenues property plant equipment geographic areas follows years ended march in millions revenues united states international total property plant equipment net year end united states international total international operations primarily consist canadian pharmaceutical healthcareproducts distribution business investment nadro pharmaceutical solutionssegment our provider technologies business operations canada united kingdom othereuropean countries israel we also software manufacturing printing facility inireland net revenues attributed geographic areas based customers shipmentlocations in april reorganized certain businesses as result report neworganizational structure retroactive basis beginning first quarter table contents mckesson corporation financial notes concluded quarterly financial information unaudited first second third fourth in millions except per share amounts quarter quarter quarter quarter year fiscal revenues gross profit income lossafter incometaxes continuing operations discontinued operations total earnings lossper commonshare diluted continuing operations discontinued operations total basic continuing operations discontinued operations total cash dividends per commonshare market prices per common share high low fiscal revenues gross profit income lossafter incometaxes continuing operations discontinued operations total earnings lossper commonshare diluted continuing operations discontinued operations total basic continuing operations discontinued operations total cash dividends per commonshare market prices per common share high low income lossafter income taxes earnings lossper common share includes charges andcredits relating securities litigation discussed financial note table contents mckesson corporation directors and officers board of directors corporate officers john hammergren john hammergren chairman president chairman president chief executive officer chief executive officer mckesson corporation wayne budd jeffrey campbell senior counsel executive vice president goodwin procter llp chief financial officer alton irby iii paul julian chairman founding partner executive vice president london bay capital group president christine jacobs paul kirincic president executive vice president human resources chief executive officer theragenics corporation nicholas loiacono vice president treasurer marie knowles executive vice president marc owen chief financial officer retired executive vice president corporate strategy atlantic richfield company business development david lawrence md pamela pure chairman chief executive officer retired executive vice president kaiser foundation health plan inc president mckesson provider technologies kaiser foundation hospitals nigel rees robert matschullat vice president controller vice chairman chief financial officer retired the seagram company ltd laureen seeger executive vice president general counsel james napier secretary chairman board retired scientific atlanta inc randall spratt executive vice president jane shaw phd chief information officer chairman chief executive officer retired aerogen inc table contents mckesson corporation corporate information common stock mckesson corporation common stock listed new york stock exchange ticker symbol mckand quoted daily stock tables carried newspapers stockholder information the bank new york barclay street east new york ny acts transfer agentregistrar dividend paying agent dividend reinvestment plan agent mckesson corporationstock maintains registered stockholder records company for information aboutmckesson corporation stock request replacement lost dividend checks stock certificates divs dividend check deposited directly checking savingsaccount stockholders may call the bank new yorks telephone response center weekdays pm et for hearing impaired call the bank ofnew york also web site httpstockbankofnycom stockholders may use hours dayto request account information an interactive voice response system available hours dayseven days week dividends dividend reinvestment plan dividends generally paid first business day january april july octobermckesson corporations dividend reinvestment plan offers stockholders opportunity reinvestdividends common stock purchase additional shares common stock stock anindividuals dividend reinvestment plan held book entry companys transfer agent thebank new york for information request enrollment form call the bank newyorks telephone response center from outside united states call annual meeting mckesson corporations annual meeting stockholders held pdt onwednesday july giannini auditorium california street san franciscocalifornia